source name	characteristics[organism]	characteristics[organism part]	characteristics[individual]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[developmental stage]	characteristics[disease]	characteristics[depletion]	characteristics[biological replicate]	characteristics[sampling time]	assay name	Technology type	comment[data file]	comment[file uri]	comment[fraction identifier]	comment[fractionation method]	comment[label]	comment[technical replicate]	comment[instrument]	comment[cleavage agent details]	comment[MS2 mass analyzer]	comment[instrument]	comment[proteomics data acquisition method]	comment[modification parameter]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[organism part]
PXD030598-Sample-1	Homo sapiens	blood plasma	1	not applicable	not available	34	Female	not available	Normal	depleted	1	not applicable	RHD01_100_1	proteomic profiling by mass spectrometry	RHD01_100_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_100_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-1	Homo sapiens	blood plasma	1	not applicable	not available	34	Female	not available	Normal	depleted	1	not applicable	RHD01_100_2	proteomic profiling by mass spectrometry	RHD01_100_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_100_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-2	Homo sapiens	blood plasma	2	not applicable	not available	46	Female	not available	Normal	depleted	2	not applicable	RHD01_101_1	proteomic profiling by mass spectrometry	RHD01_101_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_101_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-2	Homo sapiens	blood plasma	2	not applicable	not available	46	Female	not available	Normal	depleted	2	not applicable	RHD01_101_2	proteomic profiling by mass spectrometry	RHD01_101_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_101_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-3	Homo sapiens	blood plasma	3	not applicable	not available	28	Female	not available	Normal	depleted	3	not applicable	RHD01_102_1	proteomic profiling by mass spectrometry	RHD01_102_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_102_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-3	Homo sapiens	blood plasma	3	not applicable	not available	28	Female	not available	Normal	depleted	3	not applicable	RHD01_102_2	proteomic profiling by mass spectrometry	RHD01_102_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_102_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-4	Homo sapiens	blood plasma	4	not applicable	not available	45	Male	not available	Normal	depleted	4	not applicable	RHD01_103_1	proteomic profiling by mass spectrometry	RHD01_103_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_103_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-4	Homo sapiens	blood plasma	4	not applicable	not available	45	Male	not available	Normal	depleted	4	not applicable	RHD01_103_2	proteomic profiling by mass spectrometry	RHD01_103_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_103_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-5	Homo sapiens	blood plasma	5	not applicable	not available	53	Female	not available	Rheumatic Heart Disease	depleted	5	not applicable	RHD01_104_1	proteomic profiling by mass spectrometry	RHD01_104_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_104_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-5	Homo sapiens	blood plasma	5	not applicable	not available	53	Female	not available	Rheumatic Heart Disease	depleted	5	not applicable	RHD01_104_2	proteomic profiling by mass spectrometry	RHD01_104_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_104_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-6	Homo sapiens	blood plasma	6	not applicable	not available	42	Female	not available	Normal	depleted	6	not applicable	RHD01_105_1	proteomic profiling by mass spectrometry	RHD01_105_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_105_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-6	Homo sapiens	blood plasma	6	not applicable	not available	42	Female	not available	Normal	depleted	6	not applicable	RHD01_105_2	proteomic profiling by mass spectrometry	RHD01_105_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_105_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-7	Homo sapiens	blood plasma	7	not applicable	not available	22	Female	not available	Rheumatic Heart Disease	depleted	7	not applicable	RHD01_106_1	proteomic profiling by mass spectrometry	RHD01_106_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_106_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-7	Homo sapiens	blood plasma	7	not applicable	not available	22	Female	not available	Rheumatic Heart Disease	depleted	7	not applicable	RHD01_106_2	proteomic profiling by mass spectrometry	RHD01_106_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_106_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-8	Homo sapiens	blood plasma	8	not applicable	not available	40	Female	not available	Normal	depleted	8	not applicable	RHD01_107_1	proteomic profiling by mass spectrometry	RHD01_107_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_107_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-8	Homo sapiens	blood plasma	8	not applicable	not available	40	Female	not available	Normal	depleted	8	not applicable	RHD01_107_2	proteomic profiling by mass spectrometry	RHD01_107_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_107_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-9	Homo sapiens	blood plasma	9	not applicable	not available	25	Female	not available	Rheumatic Heart Disease	depleted	9	not applicable	RHD01_109_1	proteomic profiling by mass spectrometry	RHD01_109_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_109_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-9	Homo sapiens	blood plasma	9	not applicable	not available	25	Female	not available	Rheumatic Heart Disease	depleted	9	not applicable	RHD01_109_2	proteomic profiling by mass spectrometry	RHD01_109_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_109_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-10	Homo sapiens	blood plasma	10	not applicable	not available	26	Male	not available	Normal	depleted	10	not applicable	RHD01_10_1	proteomic profiling by mass spectrometry	RHD01_10_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_10_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-10	Homo sapiens	blood plasma	10	not applicable	not available	26	Male	not available	Normal	depleted	10	not applicable	RHD01_10_2	proteomic profiling by mass spectrometry	RHD01_10_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_10_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-11	Homo sapiens	blood plasma	11	not applicable	not available	43	Female	not available	Rheumatic Heart Disease	depleted	11	not applicable	RHD01_110PR_1	proteomic profiling by mass spectrometry	RHD01_110PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_110PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-11	Homo sapiens	blood plasma	11	not applicable	not available	43	Female	not available	Rheumatic Heart Disease	depleted	11	not applicable	RHD01_110PR_2	proteomic profiling by mass spectrometry	RHD01_110PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_110PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-12	Homo sapiens	blood plasma	12	not applicable	not available	21	Female	not available	Normal	depleted	12	not applicable	RHD01_111_1	proteomic profiling by mass spectrometry	RHD01_111_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_111_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-12	Homo sapiens	blood plasma	12	not applicable	not available	21	Female	not available	Normal	depleted	12	not applicable	RHD01_111_2	proteomic profiling by mass spectrometry	RHD01_111_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_111_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-13	Homo sapiens	blood plasma	13	not applicable	not available	31	Female	not available	Normal	depleted	13	not applicable	RHD01_112_1	proteomic profiling by mass spectrometry	RHD01_112_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_112_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-13	Homo sapiens	blood plasma	13	not applicable	not available	31	Female	not available	Normal	depleted	13	not applicable	RHD01_112_2	proteomic profiling by mass spectrometry	RHD01_112_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_112_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-14	Homo sapiens	blood plasma	14	not applicable	not available	33	Male	not available	Normal	depleted	14	not applicable	RHD01_113_1	proteomic profiling by mass spectrometry	RHD01_113_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_113_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-14	Homo sapiens	blood plasma	14	not applicable	not available	33	Male	not available	Normal	depleted	14	not applicable	RHD01_113_2	proteomic profiling by mass spectrometry	RHD01_113_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_113_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-15	Homo sapiens	blood plasma	15	not applicable	not available	23	Female	not available	Normal	depleted	15	not applicable	RHD01_114_1	proteomic profiling by mass spectrometry	RHD01_114_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_114_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-15	Homo sapiens	blood plasma	15	not applicable	not available	23	Female	not available	Normal	depleted	15	not applicable	RHD01_114_2	proteomic profiling by mass spectrometry	RHD01_114_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_114_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-16	Homo sapiens	blood plasma	16	not applicable	not available	32	Female	not available	Normal	depleted	16	not applicable	RHD01_115_1	proteomic profiling by mass spectrometry	RHD01_115_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_115_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-16	Homo sapiens	blood plasma	16	not applicable	not available	32	Female	not available	Normal	depleted	16	not applicable	RHD01_115_2	proteomic profiling by mass spectrometry	RHD01_115_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_115_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-17	Homo sapiens	blood plasma	17	not applicable	not available	10	Female	not available	Rheumatic Heart Disease	depleted	17	not applicable	RHD01_116_1	proteomic profiling by mass spectrometry	RHD01_116_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_116_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-17	Homo sapiens	blood plasma	17	not applicable	not available	10	Female	not available	Rheumatic Heart Disease	depleted	17	not applicable	RHD01_116_2	proteomic profiling by mass spectrometry	RHD01_116_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_116_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-18	Homo sapiens	blood plasma	18	not applicable	not available	22	Female	not available	Normal	depleted	18	not applicable	RHD01_117_1	proteomic profiling by mass spectrometry	RHD01_117_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_117_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-18	Homo sapiens	blood plasma	18	not applicable	not available	22	Female	not available	Normal	depleted	18	not applicable	RHD01_117_2	proteomic profiling by mass spectrometry	RHD01_117_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_117_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-19	Homo sapiens	blood plasma	19	not applicable	not available	23	Female	not available	Rheumatic Heart Disease	depleted	19	not applicable	RHD01_118_1	proteomic profiling by mass spectrometry	RHD01_118_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_118_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-19	Homo sapiens	blood plasma	19	not applicable	not available	23	Female	not available	Rheumatic Heart Disease	depleted	19	not applicable	RHD01_118_2	proteomic profiling by mass spectrometry	RHD01_118_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_118_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-20	Homo sapiens	blood plasma	20	not applicable	not available	32	Male	not available	Rheumatic Heart Disease	depleted	20	not applicable	RHD01_119_1	proteomic profiling by mass spectrometry	RHD01_119_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_119_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-20	Homo sapiens	blood plasma	20	not applicable	not available	32	Male	not available	Rheumatic Heart Disease	depleted	20	not applicable	RHD01_119_2	proteomic profiling by mass spectrometry	RHD01_119_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_119_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-21	Homo sapiens	blood plasma	21	not applicable	not available	24	Female	not available	Normal	depleted	21	not applicable	RHD01_11_1	proteomic profiling by mass spectrometry	RHD01_11_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_11_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-21	Homo sapiens	blood plasma	21	not applicable	not available	24	Female	not available	Normal	depleted	21	not applicable	RHD01_11_2	proteomic profiling by mass spectrometry	RHD01_11_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_11_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-22	Homo sapiens	blood plasma	22	not applicable	not available	12	Male	not available	Rheumatic Heart Disease	depleted	22	not applicable	RHD01_120_1	proteomic profiling by mass spectrometry	RHD01_120_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_120_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-22	Homo sapiens	blood plasma	22	not applicable	not available	12	Male	not available	Rheumatic Heart Disease	depleted	22	not applicable	RHD01_120_2	proteomic profiling by mass spectrometry	RHD01_120_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_120_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-23	Homo sapiens	blood plasma	23	not applicable	not available	21	Male	not available	Normal	depleted	23	not applicable	RHD01_121_1	proteomic profiling by mass spectrometry	RHD01_121_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_121_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-23	Homo sapiens	blood plasma	23	not applicable	not available	21	Male	not available	Normal	depleted	23	not applicable	RHD01_121_2	proteomic profiling by mass spectrometry	RHD01_121_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_121_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-24	Homo sapiens	blood plasma	24	not applicable	not available	11	Female	not available	Normal	depleted	24	not applicable	RHD01_122_1	proteomic profiling by mass spectrometry	RHD01_122_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_122_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-24	Homo sapiens	blood plasma	24	not applicable	not available	11	Female	not available	Normal	depleted	24	not applicable	RHD01_122_2	proteomic profiling by mass spectrometry	RHD01_122_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_122_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-25	Homo sapiens	blood plasma	25	not applicable	not available	57	Male	not available	Normal	depleted	25	not applicable	RHD01_123_1	proteomic profiling by mass spectrometry	RHD01_123_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_123_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-25	Homo sapiens	blood plasma	25	not applicable	not available	57	Male	not available	Normal	depleted	25	not applicable	RHD01_123_2	proteomic profiling by mass spectrometry	RHD01_123_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_123_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-26	Homo sapiens	blood plasma	26	not applicable	not available	74	Female	not available	Rheumatic Heart Disease	depleted	26	not applicable	RHD01_124_1	proteomic profiling by mass spectrometry	RHD01_124_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_124_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-26	Homo sapiens	blood plasma	26	not applicable	not available	74	Female	not available	Rheumatic Heart Disease	depleted	26	not applicable	RHD01_124_2	proteomic profiling by mass spectrometry	RHD01_124_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_124_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-27	Homo sapiens	blood plasma	27	not applicable	not available	48	Female	not available	Normal	depleted	27	not applicable	RHD01_125_1	proteomic profiling by mass spectrometry	RHD01_125_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_125_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-27	Homo sapiens	blood plasma	27	not applicable	not available	48	Female	not available	Normal	depleted	27	not applicable	RHD01_125_2	proteomic profiling by mass spectrometry	RHD01_125_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_125_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-28	Homo sapiens	blood plasma	28	not applicable	not available	19	Male	not available	Rheumatic Heart Disease	depleted	28	not applicable	RHD01_126_1	proteomic profiling by mass spectrometry	RHD01_126_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_126_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-28	Homo sapiens	blood plasma	28	not applicable	not available	19	Male	not available	Rheumatic Heart Disease	depleted	28	not applicable	RHD01_126_2	proteomic profiling by mass spectrometry	RHD01_126_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_126_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-29	Homo sapiens	blood plasma	29	not applicable	not available	20	Female	not available	Normal	depleted	29	not applicable	RHD01_127_1	proteomic profiling by mass spectrometry	RHD01_127_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_127_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-29	Homo sapiens	blood plasma	29	not applicable	not available	20	Female	not available	Normal	depleted	29	not applicable	RHD01_127_2	proteomic profiling by mass spectrometry	RHD01_127_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_127_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-30	Homo sapiens	blood plasma	30	not applicable	not available	26	Male	not available	Normal	depleted	30	not applicable	RHD01_128_1	proteomic profiling by mass spectrometry	RHD01_128_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_128_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-30	Homo sapiens	blood plasma	30	not applicable	not available	26	Male	not available	Normal	depleted	30	not applicable	RHD01_128_2	proteomic profiling by mass spectrometry	RHD01_128_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_128_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-31	Homo sapiens	blood plasma	31	not applicable	not available	36	Female	not available	Rheumatic Heart Disease	depleted	31	not applicable	RHD01_129_1	proteomic profiling by mass spectrometry	RHD01_129_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_129_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-31	Homo sapiens	blood plasma	31	not applicable	not available	36	Female	not available	Rheumatic Heart Disease	depleted	31	not applicable	RHD01_129_2	proteomic profiling by mass spectrometry	RHD01_129_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_129_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-32	Homo sapiens	blood plasma	32	not applicable	not available	24	Male	not available	Normal	depleted	32	not applicable	RHD01_12_1	proteomic profiling by mass spectrometry	RHD01_12_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_12_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-32	Homo sapiens	blood plasma	32	not applicable	not available	24	Male	not available	Normal	depleted	32	not applicable	RHD01_12_2	proteomic profiling by mass spectrometry	RHD01_12_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_12_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-33	Homo sapiens	blood plasma	33	not applicable	not available	37	Male	not available	Rheumatic Heart Disease	depleted	33	not applicable	RHD01_130_1	proteomic profiling by mass spectrometry	RHD01_130_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_130_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-33	Homo sapiens	blood plasma	33	not applicable	not available	37	Male	not available	Rheumatic Heart Disease	depleted	33	not applicable	RHD01_130_2	proteomic profiling by mass spectrometry	RHD01_130_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_130_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-34	Homo sapiens	blood plasma	34	not applicable	not available	26	Female	not available	Normal	depleted	34	not applicable	RHD01_131_1	proteomic profiling by mass spectrometry	RHD01_131_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_131_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-34	Homo sapiens	blood plasma	34	not applicable	not available	26	Female	not available	Normal	depleted	34	not applicable	RHD01_131_2	proteomic profiling by mass spectrometry	RHD01_131_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_131_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-35	Homo sapiens	blood plasma	35	not applicable	not available	28	Female	not available	Normal	depleted	35	not applicable	RHD01_132_1	proteomic profiling by mass spectrometry	RHD01_132_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_132_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-35	Homo sapiens	blood plasma	35	not applicable	not available	28	Female	not available	Normal	depleted	35	not applicable	RHD01_132_2	proteomic profiling by mass spectrometry	RHD01_132_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_132_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-36	Homo sapiens	blood plasma	36	not applicable	not available	41	Female	not available	Normal	depleted	36	not applicable	RHD01_133_1	proteomic profiling by mass spectrometry	RHD01_133_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_133_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-36	Homo sapiens	blood plasma	36	not applicable	not available	41	Female	not available	Normal	depleted	36	not applicable	RHD01_133_2	proteomic profiling by mass spectrometry	RHD01_133_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_133_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-37	Homo sapiens	blood plasma	37	not applicable	not available	10	Male	not available	Rheumatic Heart Disease	depleted	37	not applicable	RHD01_134_1	proteomic profiling by mass spectrometry	RHD01_134_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_134_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-37	Homo sapiens	blood plasma	37	not applicable	not available	10	Male	not available	Rheumatic Heart Disease	depleted	37	not applicable	RHD01_134_2	proteomic profiling by mass spectrometry	RHD01_134_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_134_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-38	Homo sapiens	blood plasma	38	not applicable	not available	67	Female	not available	Rheumatic Heart Disease	depleted	38	not applicable	RHD01_136_1	proteomic profiling by mass spectrometry	RHD01_136_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_136_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-38	Homo sapiens	blood plasma	38	not applicable	not available	67	Female	not available	Rheumatic Heart Disease	depleted	38	not applicable	RHD01_136_2	proteomic profiling by mass spectrometry	RHD01_136_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_136_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	21	Female	not available	Normal	depleted	39	not applicable	RHD01_137_1	proteomic profiling by mass spectrometry	RHD01_137_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_137_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-39	Homo sapiens	blood plasma	39	not applicable	not available	21	Female	not available	Normal	depleted	39	not applicable	RHD01_137_2	proteomic profiling by mass spectrometry	RHD01_137_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_137_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-40	Homo sapiens	blood plasma	40	not applicable	not available	15	Male	not available	Rheumatic Heart Disease	depleted	40	not applicable	RHD01_138_1	proteomic profiling by mass spectrometry	RHD01_138_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_138_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-40	Homo sapiens	blood plasma	40	not applicable	not available	15	Male	not available	Rheumatic Heart Disease	depleted	40	not applicable	RHD01_138_2	proteomic profiling by mass spectrometry	RHD01_138_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_138_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-41	Homo sapiens	blood plasma	41	not applicable	not available	41	Female	not available	Rheumatic Heart Disease	depleted	41	not applicable	RHD01_139_1	proteomic profiling by mass spectrometry	RHD01_139_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_139_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-41	Homo sapiens	blood plasma	41	not applicable	not available	41	Female	not available	Rheumatic Heart Disease	depleted	41	not applicable	RHD01_139_2	proteomic profiling by mass spectrometry	RHD01_139_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_139_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-42	Homo sapiens	blood plasma	42	not applicable	not available	42	Male	not available	Normal	depleted	42	not applicable	RHD01_13_1	proteomic profiling by mass spectrometry	RHD01_13_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_13_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-42	Homo sapiens	blood plasma	42	not applicable	not available	42	Male	not available	Normal	depleted	42	not applicable	RHD01_13_2	proteomic profiling by mass spectrometry	RHD01_13_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_13_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-43	Homo sapiens	blood plasma	43	not applicable	not available	34	Male	not available	Rheumatic Heart Disease	depleted	43	not applicable	RHD01_141_1	proteomic profiling by mass spectrometry	RHD01_141_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_141_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-43	Homo sapiens	blood plasma	43	not applicable	not available	34	Male	not available	Rheumatic Heart Disease	depleted	43	not applicable	RHD01_141_2	proteomic profiling by mass spectrometry	RHD01_141_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_141_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	23	Female	not available	Rheumatic Heart Disease	depleted	44	not applicable	RHD01_142_1	proteomic profiling by mass spectrometry	RHD01_142_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_142_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-44	Homo sapiens	blood plasma	44	not applicable	not available	23	Female	not available	Rheumatic Heart Disease	depleted	44	not applicable	RHD01_142_2	proteomic profiling by mass spectrometry	RHD01_142_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_142_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-45	Homo sapiens	blood plasma	45	not applicable	not available	4	Male	not available	Rheumatic Heart Disease	depleted	45	not applicable	RHD01_143_1	proteomic profiling by mass spectrometry	RHD01_143_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_143_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-45	Homo sapiens	blood plasma	45	not applicable	not available	4	Male	not available	Rheumatic Heart Disease	depleted	45	not applicable	RHD01_143_2	proteomic profiling by mass spectrometry	RHD01_143_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_143_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-46	Homo sapiens	blood plasma	46	not applicable	not available	59	Male	not available	Normal	depleted	46	not applicable	RHD01_144_1	proteomic profiling by mass spectrometry	RHD01_144_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_144_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-46	Homo sapiens	blood plasma	46	not applicable	not available	59	Male	not available	Normal	depleted	46	not applicable	RHD01_144_2	proteomic profiling by mass spectrometry	RHD01_144_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_144_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-47	Homo sapiens	blood plasma	47	not applicable	not available	18	Male	not available	Rheumatic Heart Disease	depleted	47	not applicable	RHD01_145_1	proteomic profiling by mass spectrometry	RHD01_145_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_145_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-47	Homo sapiens	blood plasma	47	not applicable	not available	18	Male	not available	Rheumatic Heart Disease	depleted	47	not applicable	RHD01_145_2	proteomic profiling by mass spectrometry	RHD01_145_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_145_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-48	Homo sapiens	blood plasma	48	not applicable	not available	29	Female	not available	Normal	depleted	48	not applicable	RHD01_146_1	proteomic profiling by mass spectrometry	RHD01_146_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_146_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-48	Homo sapiens	blood plasma	48	not applicable	not available	29	Female	not available	Normal	depleted	48	not applicable	RHD01_146_2	proteomic profiling by mass spectrometry	RHD01_146_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_146_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-49	Homo sapiens	blood plasma	49	not applicable	not available	9	Male	not available	Rheumatic Heart Disease	depleted	49	not applicable	RHD01_147_1	proteomic profiling by mass spectrometry	RHD01_147_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_147_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-49	Homo sapiens	blood plasma	49	not applicable	not available	9	Male	not available	Rheumatic Heart Disease	depleted	49	not applicable	RHD01_147_2	proteomic profiling by mass spectrometry	RHD01_147_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_147_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-50	Homo sapiens	blood plasma	50	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	50	not applicable	RHD01_148_1	proteomic profiling by mass spectrometry	RHD01_148_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_148_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-50	Homo sapiens	blood plasma	50	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	50	not applicable	RHD01_148_2	proteomic profiling by mass spectrometry	RHD01_148_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_148_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-51	Homo sapiens	blood plasma	51	not applicable	not available	39	Female	not available	Normal	depleted	51	not applicable	RHD01_149PR_1	proteomic profiling by mass spectrometry	RHD01_149PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_149PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-51	Homo sapiens	blood plasma	51	not applicable	not available	39	Female	not available	Normal	depleted	51	not applicable	RHD01_149PR_2	proteomic profiling by mass spectrometry	RHD01_149PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_149PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-52	Homo sapiens	blood plasma	52	not applicable	not available	43	Female	not available	Normal	depleted	52	not applicable	RHD01_150_1	proteomic profiling by mass spectrometry	RHD01_150_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_150_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-52	Homo sapiens	blood plasma	52	not applicable	not available	43	Female	not available	Normal	depleted	52	not applicable	RHD01_150_2	proteomic profiling by mass spectrometry	RHD01_150_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_150_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-53	Homo sapiens	blood plasma	53	not applicable	not available	32	Female	not available	Normal	depleted	53	not applicable	RHD01_151_1	proteomic profiling by mass spectrometry	RHD01_151_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_151_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-53	Homo sapiens	blood plasma	53	not applicable	not available	32	Female	not available	Normal	depleted	53	not applicable	RHD01_151_2	proteomic profiling by mass spectrometry	RHD01_151_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_151_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-54	Homo sapiens	blood plasma	54	not applicable	not available	48	Female	not available	Rheumatic Heart Disease	depleted	54	not applicable	RHD01_152_1	proteomic profiling by mass spectrometry	RHD01_152_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_152_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-54	Homo sapiens	blood plasma	54	not applicable	not available	48	Female	not available	Rheumatic Heart Disease	depleted	54	not applicable	RHD01_152_2	proteomic profiling by mass spectrometry	RHD01_152_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_152_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-55	Homo sapiens	blood plasma	55	not applicable	not available	19	Female	not available	Rheumatic Heart Disease	depleted	55	not applicable	RHD01_153PR_1	proteomic profiling by mass spectrometry	RHD01_153PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_153PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-55	Homo sapiens	blood plasma	55	not applicable	not available	19	Female	not available	Rheumatic Heart Disease	depleted	55	not applicable	RHD01_153PR_2	proteomic profiling by mass spectrometry	RHD01_153PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_153PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-56	Homo sapiens	blood plasma	56	not applicable	not available	41	Female	not available	Normal	depleted	56	not applicable	RHD01_154_1	proteomic profiling by mass spectrometry	RHD01_154_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_154_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-56	Homo sapiens	blood plasma	56	not applicable	not available	41	Female	not available	Normal	depleted	56	not applicable	RHD01_154_2	proteomic profiling by mass spectrometry	RHD01_154_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_154_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-57	Homo sapiens	blood plasma	57	not applicable	not available	17	Female	not available	Normal	depleted	57	not applicable	RHD01_155PR_1	proteomic profiling by mass spectrometry	RHD01_155PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_155PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-57	Homo sapiens	blood plasma	57	not applicable	not available	17	Female	not available	Normal	depleted	57	not applicable	RHD01_155PR_2	proteomic profiling by mass spectrometry	RHD01_155PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_155PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-58	Homo sapiens	blood plasma	58	not applicable	not available	11	Male	not available	Rheumatic Heart Disease	depleted	58	not applicable	RHD01_156PR_1	proteomic profiling by mass spectrometry	RHD01_156PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_156PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-58	Homo sapiens	blood plasma	58	not applicable	not available	11	Male	not available	Rheumatic Heart Disease	depleted	58	not applicable	RHD01_156PR_2	proteomic profiling by mass spectrometry	RHD01_156PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_156PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-59	Homo sapiens	blood plasma	59	not applicable	not available	21	Male	not available	Normal	depleted	59	not applicable	RHD01_157PR_1	proteomic profiling by mass spectrometry	RHD01_157PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_157PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-59	Homo sapiens	blood plasma	59	not applicable	not available	21	Male	not available	Normal	depleted	59	not applicable	RHD01_157PR_2	proteomic profiling by mass spectrometry	RHD01_157PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_157PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-60	Homo sapiens	blood plasma	60	not applicable	not available	24	Female	not available	Normal	depleted	60	not applicable	RHD01_158_1	proteomic profiling by mass spectrometry	RHD01_158_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_158_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-60	Homo sapiens	blood plasma	60	not applicable	not available	24	Female	not available	Normal	depleted	60	not applicable	RHD01_158_2	proteomic profiling by mass spectrometry	RHD01_158_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_158_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-61	Homo sapiens	blood plasma	61	not applicable	not available	46	Female	not available	Normal	depleted	61	not applicable	RHD01_160_1	proteomic profiling by mass spectrometry	RHD01_160_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_160_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-61	Homo sapiens	blood plasma	61	not applicable	not available	46	Female	not available	Normal	depleted	61	not applicable	RHD01_160_2	proteomic profiling by mass spectrometry	RHD01_160_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_160_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-62	Homo sapiens	blood plasma	62	not applicable	not available	12	Male	not available	Rheumatic Heart Disease	depleted	62	not applicable	RHD01_161_1	proteomic profiling by mass spectrometry	RHD01_161_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_161_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-62	Homo sapiens	blood plasma	62	not applicable	not available	12	Male	not available	Rheumatic Heart Disease	depleted	62	not applicable	RHD01_161_2	proteomic profiling by mass spectrometry	RHD01_161_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_161_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-63	Homo sapiens	blood plasma	63	not applicable	not available	6	Female	not available	Rheumatic Heart Disease	depleted	63	not applicable	RHD01_162_1	proteomic profiling by mass spectrometry	RHD01_162_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_162_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-63	Homo sapiens	blood plasma	63	not applicable	not available	6	Female	not available	Rheumatic Heart Disease	depleted	63	not applicable	RHD01_162_2	proteomic profiling by mass spectrometry	RHD01_162_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_162_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-64	Homo sapiens	blood plasma	64	not applicable	not available	41	Male	not available	Rheumatic Heart Disease	depleted	64	not applicable	RHD01_163_1	proteomic profiling by mass spectrometry	RHD01_163_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_163_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-64	Homo sapiens	blood plasma	64	not applicable	not available	41	Male	not available	Rheumatic Heart Disease	depleted	64	not applicable	RHD01_163_2	proteomic profiling by mass spectrometry	RHD01_163_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_163_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-65	Homo sapiens	blood plasma	65	not applicable	not available	32	Male	not available	Normal	depleted	65	not applicable	RHD01_164_1	proteomic profiling by mass spectrometry	RHD01_164_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_164_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-65	Homo sapiens	blood plasma	65	not applicable	not available	32	Male	not available	Normal	depleted	65	not applicable	RHD01_164_2	proteomic profiling by mass spectrometry	RHD01_164_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_164_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-66	Homo sapiens	blood plasma	66	not applicable	not available	33	Female	not available	Normal	depleted	66	not applicable	RHD01_165PR_1	proteomic profiling by mass spectrometry	RHD01_165PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_165PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-66	Homo sapiens	blood plasma	66	not applicable	not available	33	Female	not available	Normal	depleted	66	not applicable	RHD01_165PR_2	proteomic profiling by mass spectrometry	RHD01_165PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_165PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-67	Homo sapiens	blood plasma	67	not applicable	not available	37	Female	not available	Normal	depleted	67	not applicable	RHD01_168_1	proteomic profiling by mass spectrometry	RHD01_168_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_168_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-67	Homo sapiens	blood plasma	67	not applicable	not available	37	Female	not available	Normal	depleted	67	not applicable	RHD01_168_2	proteomic profiling by mass spectrometry	RHD01_168_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_168_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-68	Homo sapiens	blood plasma	68	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	68	not applicable	RHD01_169_1	proteomic profiling by mass spectrometry	RHD01_169_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_169_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-68	Homo sapiens	blood plasma	68	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	68	not applicable	RHD01_169_2	proteomic profiling by mass spectrometry	RHD01_169_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_169_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-69	Homo sapiens	blood plasma	69	not applicable	not available	46	Female	not available	Rheumatic Heart Disease	depleted	69	not applicable	RHD01_170_1	proteomic profiling by mass spectrometry	RHD01_170_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_170_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-69	Homo sapiens	blood plasma	69	not applicable	not available	46	Female	not available	Rheumatic Heart Disease	depleted	69	not applicable	RHD01_170_2	proteomic profiling by mass spectrometry	RHD01_170_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_170_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-70	Homo sapiens	blood plasma	70	not applicable	not available	48	Female	not available	Normal	depleted	70	not applicable	RHD01_171_1	proteomic profiling by mass spectrometry	RHD01_171_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_171_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-70	Homo sapiens	blood plasma	70	not applicable	not available	48	Female	not available	Normal	depleted	70	not applicable	RHD01_171_2	proteomic profiling by mass spectrometry	RHD01_171_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_171_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-71	Homo sapiens	blood plasma	71	not applicable	not available	15	Male	not available	Rheumatic Heart Disease	depleted	71	not applicable	RHD01_172PR_1	proteomic profiling by mass spectrometry	RHD01_172PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_172PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-71	Homo sapiens	blood plasma	71	not applicable	not available	15	Male	not available	Rheumatic Heart Disease	depleted	71	not applicable	RHD01_172PR_2	proteomic profiling by mass spectrometry	RHD01_172PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_172PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-72	Homo sapiens	blood plasma	72	not applicable	not available	12	Male	not available	Rheumatic Heart Disease	depleted	72	not applicable	RHD01_173_1	proteomic profiling by mass spectrometry	RHD01_173_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_173_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-72	Homo sapiens	blood plasma	72	not applicable	not available	12	Male	not available	Rheumatic Heart Disease	depleted	72	not applicable	RHD01_173_2	proteomic profiling by mass spectrometry	RHD01_173_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_173_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-73	Homo sapiens	blood plasma	73	not applicable	not available	42	Female	not available	Normal	depleted	73	not applicable	RHD01_174_1	proteomic profiling by mass spectrometry	RHD01_174_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_174_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-73	Homo sapiens	blood plasma	73	not applicable	not available	42	Female	not available	Normal	depleted	73	not applicable	RHD01_174_2	proteomic profiling by mass spectrometry	RHD01_174_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_174_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-74	Homo sapiens	blood plasma	74	not applicable	not available	52	Female	not available	Rheumatic Heart Disease	depleted	74	not applicable	RHD01_175_1	proteomic profiling by mass spectrometry	RHD01_175_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_175_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-74	Homo sapiens	blood plasma	74	not applicable	not available	52	Female	not available	Rheumatic Heart Disease	depleted	74	not applicable	RHD01_175_2	proteomic profiling by mass spectrometry	RHD01_175_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_175_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-75	Homo sapiens	blood plasma	75	not applicable	not available	29	Female	not available	Normal	depleted	75	not applicable	RHD01_176_1	proteomic profiling by mass spectrometry	RHD01_176_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_176_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-75	Homo sapiens	blood plasma	75	not applicable	not available	29	Female	not available	Normal	depleted	75	not applicable	RHD01_176_2	proteomic profiling by mass spectrometry	RHD01_176_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_176_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-76	Homo sapiens	blood plasma	76	not applicable	not available	63	Female	not available	Rheumatic Heart Disease	depleted	76	not applicable	RHD01_177_1	proteomic profiling by mass spectrometry	RHD01_177_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_177_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-76	Homo sapiens	blood plasma	76	not applicable	not available	63	Female	not available	Rheumatic Heart Disease	depleted	76	not applicable	RHD01_177_2	proteomic profiling by mass spectrometry	RHD01_177_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_177_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-77	Homo sapiens	blood plasma	77	not applicable	not available	20	Male	not available	Rheumatic Heart Disease	depleted	77	not applicable	RHD01_178_1	proteomic profiling by mass spectrometry	RHD01_178_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_178_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-77	Homo sapiens	blood plasma	77	not applicable	not available	20	Male	not available	Rheumatic Heart Disease	depleted	77	not applicable	RHD01_178_2	proteomic profiling by mass spectrometry	RHD01_178_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_178_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-78	Homo sapiens	blood plasma	78	not applicable	not available	9	Male	not available	Rheumatic Heart Disease	depleted	78	not applicable	RHD01_179_1	proteomic profiling by mass spectrometry	RHD01_179_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_179_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-78	Homo sapiens	blood plasma	78	not applicable	not available	9	Male	not available	Rheumatic Heart Disease	depleted	78	not applicable	RHD01_179_2	proteomic profiling by mass spectrometry	RHD01_179_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_179_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-79	Homo sapiens	blood plasma	79	not applicable	not available	41	Female	not available	Normal	depleted	79	not applicable	RHD01_17_1	proteomic profiling by mass spectrometry	RHD01_17_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_17_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-79	Homo sapiens	blood plasma	79	not applicable	not available	41	Female	not available	Normal	depleted	79	not applicable	RHD01_17_2	proteomic profiling by mass spectrometry	RHD01_17_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_17_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-80	Homo sapiens	blood plasma	80	not applicable	not available	28	Male	not available	Rheumatic Heart Disease	depleted	80	not applicable	RHD01_180_1	proteomic profiling by mass spectrometry	RHD01_180_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_180_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-80	Homo sapiens	blood plasma	80	not applicable	not available	28	Male	not available	Rheumatic Heart Disease	depleted	80	not applicable	RHD01_180_2	proteomic profiling by mass spectrometry	RHD01_180_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_180_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-81	Homo sapiens	blood plasma	81	not applicable	not available	25	Male	not available	Rheumatic Heart Disease	depleted	81	not applicable	RHD01_181_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_181_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_181_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-81	Homo sapiens	blood plasma	81	not applicable	not available	25	Male	not available	Rheumatic Heart Disease	depleted	81	not applicable	RHD01_181_2_PR	proteomic profiling by mass spectrometry	RHD01_181_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_181_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-82	Homo sapiens	blood plasma	82	not applicable	not available	39	Female	not available	Rheumatic Heart Disease	depleted	82	not applicable	RHD01_182_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_182_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_182_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-82	Homo sapiens	blood plasma	82	not applicable	not available	39	Female	not available	Rheumatic Heart Disease	depleted	82	not applicable	RHD01_182_2_PR	proteomic profiling by mass spectrometry	RHD01_182_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_182_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-83	Homo sapiens	blood plasma	83	not applicable	not available	28	Female	not available	Rheumatic Heart Disease	depleted	83	not applicable	RHD01_183_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_183_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_183_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-83	Homo sapiens	blood plasma	83	not applicable	not available	28	Female	not available	Rheumatic Heart Disease	depleted	83	not applicable	RHD01_183_2_PR	proteomic profiling by mass spectrometry	RHD01_183_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_183_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-84	Homo sapiens	blood plasma	84	not applicable	not available	12	Female	not available	Rheumatic Heart Disease	depleted	84	not applicable	RHD01_184_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_184_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_184_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-84	Homo sapiens	blood plasma	84	not applicable	not available	12	Female	not available	Rheumatic Heart Disease	depleted	84	not applicable	RHD01_184_2_PR	proteomic profiling by mass spectrometry	RHD01_184_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_184_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-85	Homo sapiens	blood plasma	85	not applicable	not available	21	Male	not available	Normal	depleted	85	not applicable	RHD01_185_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_185_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_185_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-85	Homo sapiens	blood plasma	85	not applicable	not available	21	Male	not available	Normal	depleted	85	not applicable	RHD01_185_2_PR	proteomic profiling by mass spectrometry	RHD01_185_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_185_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-86	Homo sapiens	blood plasma	86	not applicable	not available	15	Male	not available	Normal	depleted	86	not applicable	RHD01_186_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_186_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_186_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-86	Homo sapiens	blood plasma	86	not applicable	not available	15	Male	not available	Normal	depleted	86	not applicable	RHD01_186_2_PR	proteomic profiling by mass spectrometry	RHD01_186_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_186_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-87	Homo sapiens	blood plasma	87	not applicable	not available	47	Female	not available	Normal	depleted	87	not applicable	RHD01_187_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_187_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_187_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-87	Homo sapiens	blood plasma	87	not applicable	not available	47	Female	not available	Normal	depleted	87	not applicable	RHD01_187_2_PR	proteomic profiling by mass spectrometry	RHD01_187_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_187_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-88	Homo sapiens	blood plasma	88	not applicable	not available	14	Female	not available	Rheumatic Heart Disease	depleted	88	not applicable	RHD01_188_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_188_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_188_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-88	Homo sapiens	blood plasma	88	not applicable	not available	14	Female	not available	Rheumatic Heart Disease	depleted	88	not applicable	RHD01_188_2_PR	proteomic profiling by mass spectrometry	RHD01_188_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_188_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-89	Homo sapiens	blood plasma	89	not applicable	not available	21	Female	not available	Normal	depleted	89	not applicable	RHD01_189_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_189_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_189_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-89	Homo sapiens	blood plasma	89	not applicable	not available	21	Female	not available	Normal	depleted	89	not applicable	RHD01_189_2_PR	proteomic profiling by mass spectrometry	RHD01_189_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_189_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-90	Homo sapiens	blood plasma	90	not applicable	not available	48	Female	not available	Normal	depleted	90	not applicable	RHD01_18_1	proteomic profiling by mass spectrometry	RHD01_18_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_18_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-90	Homo sapiens	blood plasma	90	not applicable	not available	48	Female	not available	Normal	depleted	90	not applicable	RHD01_18_2	proteomic profiling by mass spectrometry	RHD01_18_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_18_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-91	Homo sapiens	blood plasma	91	not applicable	not available	10	Female	not available	Normal	depleted	91	not applicable	RHD01_190_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_190_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_190_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-91	Homo sapiens	blood plasma	91	not applicable	not available	10	Female	not available	Normal	depleted	91	not applicable	RHD01_190_2_PR	proteomic profiling by mass spectrometry	RHD01_190_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_190_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-92	Homo sapiens	blood plasma	92	not applicable	not available	24	Female	not available	Rheumatic Heart Disease	depleted	92	not applicable	RHD01_191_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_191_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_191_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-92	Homo sapiens	blood plasma	92	not applicable	not available	24	Female	not available	Rheumatic Heart Disease	depleted	92	not applicable	RHD01_191_2_PR	proteomic profiling by mass spectrometry	RHD01_191_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_191_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-93	Homo sapiens	blood plasma	93	not applicable	not available	33	Female	not available	Rheumatic Heart Disease	depleted	93	not applicable	RHD01_192_1_PR_VR	proteomic profiling by mass spectrometry	RHD01_192_1_PR_VR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_192_1_PR_VR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-93	Homo sapiens	blood plasma	93	not applicable	not available	33	Female	not available	Rheumatic Heart Disease	depleted	93	not applicable	RHD01_192_2_PR	proteomic profiling by mass spectrometry	RHD01_192_2_PR.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_192_2_PR.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-94	Homo sapiens	blood plasma	94	not applicable	not available	41	Male	not available	Rheumatic Heart Disease	depleted	94	not applicable	RHD01_193_1	proteomic profiling by mass spectrometry	RHD01_193_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_193_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-94	Homo sapiens	blood plasma	94	not applicable	not available	41	Male	not available	Rheumatic Heart Disease	depleted	94	not applicable	RHD01_193_2	proteomic profiling by mass spectrometry	RHD01_193_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_193_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-95	Homo sapiens	blood plasma	95	not applicable	not available	31	Female	not available	Normal	depleted	95	not applicable	RHD01_194_1	proteomic profiling by mass spectrometry	RHD01_194_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_194_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-95	Homo sapiens	blood plasma	95	not applicable	not available	31	Female	not available	Normal	depleted	95	not applicable	RHD01_194_2	proteomic profiling by mass spectrometry	RHD01_194_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_194_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-96	Homo sapiens	blood plasma	96	not applicable	not available	24	Female	not available	Normal	depleted	96	not applicable	RHD01_195_1	proteomic profiling by mass spectrometry	RHD01_195_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_195_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-96	Homo sapiens	blood plasma	96	not applicable	not available	24	Female	not available	Normal	depleted	96	not applicable	RHD01_195_2	proteomic profiling by mass spectrometry	RHD01_195_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_195_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-97	Homo sapiens	blood plasma	97	not applicable	not available	41	Male	not available	Rheumatic Heart Disease	depleted	97	not applicable	RHD01_196_1	proteomic profiling by mass spectrometry	RHD01_196_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_196_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-97	Homo sapiens	blood plasma	97	not applicable	not available	41	Male	not available	Rheumatic Heart Disease	depleted	97	not applicable	RHD01_196_2	proteomic profiling by mass spectrometry	RHD01_196_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_196_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-98	Homo sapiens	blood plasma	98	not applicable	not available	25	Male	not available	Normal	depleted	98	not applicable	RHD01_197_1	proteomic profiling by mass spectrometry	RHD01_197_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_197_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-98	Homo sapiens	blood plasma	98	not applicable	not available	25	Male	not available	Normal	depleted	98	not applicable	RHD01_197_2	proteomic profiling by mass spectrometry	RHD01_197_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_197_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-99	Homo sapiens	blood plasma	99	not applicable	not available	45	Female	not available	Normal	depleted	99	not applicable	RHD01_198_1	proteomic profiling by mass spectrometry	RHD01_198_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_198_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-99	Homo sapiens	blood plasma	99	not applicable	not available	45	Female	not available	Normal	depleted	99	not applicable	RHD01_198_2	proteomic profiling by mass spectrometry	RHD01_198_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_198_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-100	Homo sapiens	blood plasma	100	not applicable	not available	5	Female	not available	Rheumatic Heart Disease	depleted	100	not applicable	RHD01_199_1	proteomic profiling by mass spectrometry	RHD01_199_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_199_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-100	Homo sapiens	blood plasma	100	not applicable	not available	5	Female	not available	Rheumatic Heart Disease	depleted	100	not applicable	RHD01_199_2	proteomic profiling by mass spectrometry	RHD01_199_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_199_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-101	Homo sapiens	blood plasma	101	not applicable	not available	50	Female	not available	Rheumatic Heart Disease	depleted	101	not applicable	RHD01_19_1	proteomic profiling by mass spectrometry	RHD01_19_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_19_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-101	Homo sapiens	blood plasma	101	not applicable	not available	50	Female	not available	Rheumatic Heart Disease	depleted	101	not applicable	RHD01_19_2	proteomic profiling by mass spectrometry	RHD01_19_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_19_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-102	Homo sapiens	blood plasma	102	not applicable	not available	17	Female	not available	Rheumatic Heart Disease	depleted	102	not applicable	RHD01_1_1	proteomic profiling by mass spectrometry	RHD01_1_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_1_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-102	Homo sapiens	blood plasma	102	not applicable	not available	17	Female	not available	Rheumatic Heart Disease	depleted	102	not applicable	RHD01_1_2	proteomic profiling by mass spectrometry	RHD01_1_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_1_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-103	Homo sapiens	blood plasma	103	not applicable	not available	17	Male	not available	Normal	depleted	103	not applicable	RHD01_200PR_1	proteomic profiling by mass spectrometry	RHD01_200PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_200PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-103	Homo sapiens	blood plasma	103	not applicable	not available	17	Male	not available	Normal	depleted	103	not applicable	RHD01_200PR_2	proteomic profiling by mass spectrometry	RHD01_200PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_200PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-104	Homo sapiens	blood plasma	104	not applicable	not available	28	Male	not available	Rheumatic Heart Disease	depleted	104	not applicable	RHD01_201_1	proteomic profiling by mass spectrometry	RHD01_201_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_201_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-104	Homo sapiens	blood plasma	104	not applicable	not available	28	Male	not available	Rheumatic Heart Disease	depleted	104	not applicable	RHD01_201_2	proteomic profiling by mass spectrometry	RHD01_201_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_201_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-105	Homo sapiens	blood plasma	105	not applicable	not available	42	Female	not available	Normal	depleted	105	not applicable	RHD01_202_1	proteomic profiling by mass spectrometry	RHD01_202_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_202_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-105	Homo sapiens	blood plasma	105	not applicable	not available	42	Female	not available	Normal	depleted	105	not applicable	RHD01_202_2	proteomic profiling by mass spectrometry	RHD01_202_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_202_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-106	Homo sapiens	blood plasma	106	not applicable	not available	40	Male	not available	Rheumatic Heart Disease	depleted	106	not applicable	RHD01_203_1	proteomic profiling by mass spectrometry	RHD01_203_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_203_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-106	Homo sapiens	blood plasma	106	not applicable	not available	40	Male	not available	Rheumatic Heart Disease	depleted	106	not applicable	RHD01_203_2	proteomic profiling by mass spectrometry	RHD01_203_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_203_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-107	Homo sapiens	blood plasma	107	not applicable	not available	62	Male	not available	Normal	depleted	107	not applicable	RHD01_204_1	proteomic profiling by mass spectrometry	RHD01_204_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_204_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-107	Homo sapiens	blood plasma	107	not applicable	not available	62	Male	not available	Normal	depleted	107	not applicable	RHD01_204_2	proteomic profiling by mass spectrometry	RHD01_204_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_204_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-108	Homo sapiens	blood plasma	108	not applicable	not available	59	Female	not available	Rheumatic Heart Disease	depleted	108	not applicable	RHD01_205_1	proteomic profiling by mass spectrometry	RHD01_205_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_205_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-108	Homo sapiens	blood plasma	108	not applicable	not available	59	Female	not available	Rheumatic Heart Disease	depleted	108	not applicable	RHD01_205_2	proteomic profiling by mass spectrometry	RHD01_205_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_205_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-109	Homo sapiens	blood plasma	109	not applicable	not available	55	Female	not available	Rheumatic Heart Disease	depleted	109	not applicable	RHD01_206_1	proteomic profiling by mass spectrometry	RHD01_206_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_206_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-109	Homo sapiens	blood plasma	109	not applicable	not available	55	Female	not available	Rheumatic Heart Disease	depleted	109	not applicable	RHD01_206_2	proteomic profiling by mass spectrometry	RHD01_206_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_206_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-110	Homo sapiens	blood plasma	110	not applicable	not available	39	Female	not available	Rheumatic Heart Disease	depleted	110	not applicable	RHD01_207_1	proteomic profiling by mass spectrometry	RHD01_207_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_207_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-110	Homo sapiens	blood plasma	110	not applicable	not available	39	Female	not available	Rheumatic Heart Disease	depleted	110	not applicable	RHD01_207_2	proteomic profiling by mass spectrometry	RHD01_207_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_207_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-111	Homo sapiens	blood plasma	111	not applicable	not available	18	Female	not available	Normal	depleted	111	not applicable	RHD01_208_1	proteomic profiling by mass spectrometry	RHD01_208_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_208_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-111	Homo sapiens	blood plasma	111	not applicable	not available	18	Female	not available	Normal	depleted	111	not applicable	RHD01_208_2	proteomic profiling by mass spectrometry	RHD01_208_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_208_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-112	Homo sapiens	blood plasma	112	not applicable	not available	59	Female	not available	Rheumatic Heart Disease	depleted	112	not applicable	RHD01_209_1	proteomic profiling by mass spectrometry	RHD01_209_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_209_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-112	Homo sapiens	blood plasma	112	not applicable	not available	59	Female	not available	Rheumatic Heart Disease	depleted	112	not applicable	RHD01_209_2	proteomic profiling by mass spectrometry	RHD01_209_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_209_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-113	Homo sapiens	blood plasma	113	not applicable	not available	28	Female	not available	Rheumatic Heart Disease	depleted	113	not applicable	RHD01_20_1	proteomic profiling by mass spectrometry	RHD01_20_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_20_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-113	Homo sapiens	blood plasma	113	not applicable	not available	28	Female	not available	Rheumatic Heart Disease	depleted	113	not applicable	RHD01_20_2	proteomic profiling by mass spectrometry	RHD01_20_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_20_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-114	Homo sapiens	blood plasma	114	not applicable	not available	17	Female	not available	Rheumatic Heart Disease	depleted	114	not applicable	RHD01_210_1	proteomic profiling by mass spectrometry	RHD01_210_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_210_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-114	Homo sapiens	blood plasma	114	not applicable	not available	17	Female	not available	Rheumatic Heart Disease	depleted	114	not applicable	RHD01_210_2	proteomic profiling by mass spectrometry	RHD01_210_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_210_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-115	Homo sapiens	blood plasma	115	not applicable	not available	42	Female	not available	Normal	depleted	115	not applicable	RHD01_211_1	proteomic profiling by mass spectrometry	RHD01_211_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_211_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-115	Homo sapiens	blood plasma	115	not applicable	not available	42	Female	not available	Normal	depleted	115	not applicable	RHD01_211_2	proteomic profiling by mass spectrometry	RHD01_211_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_211_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-116	Homo sapiens	blood plasma	116	not applicable	not available	44	Female	not available	Normal	depleted	116	not applicable	RHD01_212_1	proteomic profiling by mass spectrometry	RHD01_212_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_212_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-116	Homo sapiens	blood plasma	116	not applicable	not available	44	Female	not available	Normal	depleted	116	not applicable	RHD01_212_2	proteomic profiling by mass spectrometry	RHD01_212_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_212_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-117	Homo sapiens	blood plasma	117	not applicable	not available	43	Female	not available	Rheumatic Heart Disease	depleted	117	not applicable	RHD01_213_1	proteomic profiling by mass spectrometry	RHD01_213_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_213_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-117	Homo sapiens	blood plasma	117	not applicable	not available	43	Female	not available	Rheumatic Heart Disease	depleted	117	not applicable	RHD01_213_2	proteomic profiling by mass spectrometry	RHD01_213_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_213_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-118	Homo sapiens	blood plasma	118	not applicable	not available	43	Female	not available	Normal	depleted	118	not applicable	RHD01_214_1	proteomic profiling by mass spectrometry	RHD01_214_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_214_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-118	Homo sapiens	blood plasma	118	not applicable	not available	43	Female	not available	Normal	depleted	118	not applicable	RHD01_214_2	proteomic profiling by mass spectrometry	RHD01_214_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_214_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-119	Homo sapiens	blood plasma	119	not applicable	not available	12	Female	not available	Rheumatic Heart Disease	depleted	119	not applicable	RHD01_215_1	proteomic profiling by mass spectrometry	RHD01_215_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_215_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-119	Homo sapiens	blood plasma	119	not applicable	not available	12	Female	not available	Rheumatic Heart Disease	depleted	119	not applicable	RHD01_215_2	proteomic profiling by mass spectrometry	RHD01_215_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_215_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-120	Homo sapiens	blood plasma	120	not applicable	not available	11	Male	not available	Rheumatic Heart Disease	depleted	120	not applicable	RHD01_216_1	proteomic profiling by mass spectrometry	RHD01_216_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_216_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-120	Homo sapiens	blood plasma	120	not applicable	not available	11	Male	not available	Rheumatic Heart Disease	depleted	120	not applicable	RHD01_216_2	proteomic profiling by mass spectrometry	RHD01_216_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_216_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-121	Homo sapiens	blood plasma	121	not applicable	not available	19	Female	not available	Normal	depleted	121	not applicable	RHD01_218_2	proteomic profiling by mass spectrometry	RHD01_218_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_218_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-121	Homo sapiens	blood plasma	121	not applicable	not available	19	Female	not available	Normal	depleted	121	not applicable	RHD01_218_3	proteomic profiling by mass spectrometry	RHD01_218_3.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_218_3.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-122	Homo sapiens	blood plasma	122	not applicable	not available	23	Female	not available	Rheumatic Heart Disease	depleted	122	not applicable	RHD01_219_2	proteomic profiling by mass spectrometry	RHD01_219_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_219_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-122	Homo sapiens	blood plasma	122	not applicable	not available	23	Female	not available	Rheumatic Heart Disease	depleted	122	not applicable	RHD01_219_3	proteomic profiling by mass spectrometry	RHD01_219_3.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_219_3.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-123	Homo sapiens	blood plasma	123	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	123	not applicable	RHD01_21_1	proteomic profiling by mass spectrometry	RHD01_21_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_21_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-123	Homo sapiens	blood plasma	123	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	123	not applicable	RHD01_21_2	proteomic profiling by mass spectrometry	RHD01_21_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_21_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-124	Homo sapiens	blood plasma	124	not applicable	not available	45	Female	not available	Normal	depleted	124	not applicable	RHD01_220_2	proteomic profiling by mass spectrometry	RHD01_220_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_220_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-124	Homo sapiens	blood plasma	124	not applicable	not available	45	Female	not available	Normal	depleted	124	not applicable	RHD01_220_3	proteomic profiling by mass spectrometry	RHD01_220_3.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_220_3.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-125	Homo sapiens	blood plasma	125	not applicable	not available	15	Female	not available	Rheumatic Heart Disease	depleted	125	not applicable	RHD01_221_1	proteomic profiling by mass spectrometry	RHD01_221_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_221_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-125	Homo sapiens	blood plasma	125	not applicable	not available	15	Female	not available	Rheumatic Heart Disease	depleted	125	not applicable	RHD01_221_2	proteomic profiling by mass spectrometry	RHD01_221_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_221_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-126	Homo sapiens	blood plasma	126	not applicable	not available	52	Male	not available	Normal	depleted	126	not applicable	RHD01_222_1	proteomic profiling by mass spectrometry	RHD01_222_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_222_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-126	Homo sapiens	blood plasma	126	not applicable	not available	52	Male	not available	Normal	depleted	126	not applicable	RHD01_222_2	proteomic profiling by mass spectrometry	RHD01_222_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_222_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-127	Homo sapiens	blood plasma	127	not applicable	not available	23	Male	not available	Normal	depleted	127	not applicable	RHD01_224_1	proteomic profiling by mass spectrometry	RHD01_224_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_224_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-127	Homo sapiens	blood plasma	127	not applicable	not available	23	Male	not available	Normal	depleted	127	not applicable	RHD01_224_2	proteomic profiling by mass spectrometry	RHD01_224_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_224_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-128	Homo sapiens	blood plasma	128	not applicable	not available	31	Male	not available	Normal	depleted	128	not applicable	RHD01_225_1	proteomic profiling by mass spectrometry	RHD01_225_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_225_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-128	Homo sapiens	blood plasma	128	not applicable	not available	31	Male	not available	Normal	depleted	128	not applicable	RHD01_225_2	proteomic profiling by mass spectrometry	RHD01_225_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_225_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-129	Homo sapiens	blood plasma	129	not applicable	not available	45	Female	not available	Rheumatic Heart Disease	depleted	129	not applicable	RHD01_226_1	proteomic profiling by mass spectrometry	RHD01_226_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_226_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-129	Homo sapiens	blood plasma	129	not applicable	not available	45	Female	not available	Rheumatic Heart Disease	depleted	129	not applicable	RHD01_226_2	proteomic profiling by mass spectrometry	RHD01_226_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_226_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-130	Homo sapiens	blood plasma	130	not applicable	not available	17	Female	not available	Normal	depleted	130	not applicable	RHD01_227_1	proteomic profiling by mass spectrometry	RHD01_227_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_227_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-130	Homo sapiens	blood plasma	130	not applicable	not available	17	Female	not available	Normal	depleted	130	not applicable	RHD01_227_2	proteomic profiling by mass spectrometry	RHD01_227_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_227_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-131	Homo sapiens	blood plasma	131	not applicable	not available	18	Female	not available	Normal	depleted	131	not applicable	RHD01_228_1	proteomic profiling by mass spectrometry	RHD01_228_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_228_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-131	Homo sapiens	blood plasma	131	not applicable	not available	18	Female	not available	Normal	depleted	131	not applicable	RHD01_228_2	proteomic profiling by mass spectrometry	RHD01_228_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_228_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-132	Homo sapiens	blood plasma	132	not applicable	not available	43	Female	not available	Normal	depleted	132	not applicable	RHD01_229_1	proteomic profiling by mass spectrometry	RHD01_229_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_229_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-132	Homo sapiens	blood plasma	132	not applicable	not available	43	Female	not available	Normal	depleted	132	not applicable	RHD01_229_2	proteomic profiling by mass spectrometry	RHD01_229_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_229_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-133	Homo sapiens	blood plasma	133	not applicable	not available	30	Female	not available	Normal	depleted	133	not applicable	RHD01_22_1	proteomic profiling by mass spectrometry	RHD01_22_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_22_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-133	Homo sapiens	blood plasma	133	not applicable	not available	30	Female	not available	Normal	depleted	133	not applicable	RHD01_22_2	proteomic profiling by mass spectrometry	RHD01_22_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_22_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-134	Homo sapiens	blood plasma	134	not applicable	not available	31	Male	not available	Rheumatic Heart Disease	depleted	134	not applicable	RHD01_230_1	proteomic profiling by mass spectrometry	RHD01_230_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_230_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-134	Homo sapiens	blood plasma	134	not applicable	not available	31	Male	not available	Rheumatic Heart Disease	depleted	134	not applicable	RHD01_230_2	proteomic profiling by mass spectrometry	RHD01_230_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_230_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-135	Homo sapiens	blood plasma	135	not applicable	not available	40	Male	not available	Normal	depleted	135	not applicable	RHD01_231_1	proteomic profiling by mass spectrometry	RHD01_231_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_231_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-135	Homo sapiens	blood plasma	135	not applicable	not available	40	Male	not available	Normal	depleted	135	not applicable	RHD01_231_2	proteomic profiling by mass spectrometry	RHD01_231_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_231_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-136	Homo sapiens	blood plasma	136	not applicable	not available	46	Female	not available	Rheumatic Heart Disease	depleted	136	not applicable	RHD01_232_1	proteomic profiling by mass spectrometry	RHD01_232_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_232_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-136	Homo sapiens	blood plasma	136	not applicable	not available	46	Female	not available	Rheumatic Heart Disease	depleted	136	not applicable	RHD01_232_2	proteomic profiling by mass spectrometry	RHD01_232_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_232_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-137	Homo sapiens	blood plasma	137	not applicable	not available	44	Male	not available	Rheumatic Heart Disease	depleted	137	not applicable	RHD01_233_1	proteomic profiling by mass spectrometry	RHD01_233_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_233_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-137	Homo sapiens	blood plasma	137	not applicable	not available	44	Male	not available	Rheumatic Heart Disease	depleted	137	not applicable	RHD01_233_2	proteomic profiling by mass spectrometry	RHD01_233_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_233_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-138	Homo sapiens	blood plasma	138	not applicable	not available	40	Male	not available	Rheumatic Heart Disease	depleted	138	not applicable	RHD01_234_1	proteomic profiling by mass spectrometry	RHD01_234_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_234_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-138	Homo sapiens	blood plasma	138	not applicable	not available	40	Male	not available	Rheumatic Heart Disease	depleted	138	not applicable	RHD01_234_2	proteomic profiling by mass spectrometry	RHD01_234_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_234_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-139	Homo sapiens	blood plasma	139	not applicable	not available	37	Female	not available	Rheumatic Heart Disease	depleted	139	not applicable	RHD01_235_1	proteomic profiling by mass spectrometry	RHD01_235_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_235_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-139	Homo sapiens	blood plasma	139	not applicable	not available	37	Female	not available	Rheumatic Heart Disease	depleted	139	not applicable	RHD01_235_2	proteomic profiling by mass spectrometry	RHD01_235_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_235_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-140	Homo sapiens	blood plasma	140	not applicable	not available	32	Female	not available	Rheumatic Heart Disease	depleted	140	not applicable	RHD01_236_1	proteomic profiling by mass spectrometry	RHD01_236_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_236_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-140	Homo sapiens	blood plasma	140	not applicable	not available	32	Female	not available	Rheumatic Heart Disease	depleted	140	not applicable	RHD01_236_2	proteomic profiling by mass spectrometry	RHD01_236_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_236_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-141	Homo sapiens	blood plasma	141	not applicable	not available	18	Female	not available	Normal	depleted	141	not applicable	RHD01_237_1	proteomic profiling by mass spectrometry	RHD01_237_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_237_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-141	Homo sapiens	blood plasma	141	not applicable	not available	18	Female	not available	Normal	depleted	141	not applicable	RHD01_237_2	proteomic profiling by mass spectrometry	RHD01_237_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_237_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-142	Homo sapiens	blood plasma	142	not applicable	not available	40	Female	not available	Rheumatic Heart Disease	depleted	142	not applicable	RHD01_238_1	proteomic profiling by mass spectrometry	RHD01_238_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_238_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-142	Homo sapiens	blood plasma	142	not applicable	not available	40	Female	not available	Rheumatic Heart Disease	depleted	142	not applicable	RHD01_238_2	proteomic profiling by mass spectrometry	RHD01_238_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_238_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-143	Homo sapiens	blood plasma	143	not applicable	not available	18	Male	not available	Normal	depleted	143	not applicable	RHD01_239_1	proteomic profiling by mass spectrometry	RHD01_239_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_239_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-143	Homo sapiens	blood plasma	143	not applicable	not available	18	Male	not available	Normal	depleted	143	not applicable	RHD01_239_2	proteomic profiling by mass spectrometry	RHD01_239_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_239_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-144	Homo sapiens	blood plasma	144	not applicable	not available	10	Female	not available	Rheumatic Heart Disease	depleted	144	not applicable	RHD01_23_1	proteomic profiling by mass spectrometry	RHD01_23_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_23_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-144	Homo sapiens	blood plasma	144	not applicable	not available	10	Female	not available	Rheumatic Heart Disease	depleted	144	not applicable	RHD01_23_2	proteomic profiling by mass spectrometry	RHD01_23_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_23_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-145	Homo sapiens	blood plasma	145	not applicable	not available	17	Female	not available	Rheumatic Heart Disease	depleted	145	not applicable	RHD01_240_1	proteomic profiling by mass spectrometry	RHD01_240_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_240_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-145	Homo sapiens	blood plasma	145	not applicable	not available	17	Female	not available	Rheumatic Heart Disease	depleted	145	not applicable	RHD01_240_2	proteomic profiling by mass spectrometry	RHD01_240_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_240_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-146	Homo sapiens	blood plasma	146	not applicable	not available	14	Female	not available	Rheumatic Heart Disease	depleted	146	not applicable	RHD01_241_1	proteomic profiling by mass spectrometry	RHD01_241_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_241_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-146	Homo sapiens	blood plasma	146	not applicable	not available	14	Female	not available	Rheumatic Heart Disease	depleted	146	not applicable	RHD01_241_2	proteomic profiling by mass spectrometry	RHD01_241_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_241_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-147	Homo sapiens	blood plasma	147	not applicable	not available	62	Female	not available	Normal	depleted	147	not applicable	RHD01_242_1	proteomic profiling by mass spectrometry	RHD01_242_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_242_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-147	Homo sapiens	blood plasma	147	not applicable	not available	62	Female	not available	Normal	depleted	147	not applicable	RHD01_242_2	proteomic profiling by mass spectrometry	RHD01_242_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_242_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-148	Homo sapiens	blood plasma	148	not applicable	not available	18	Male	not available	Normal	depleted	148	not applicable	RHD01_243PR_1	proteomic profiling by mass spectrometry	RHD01_243PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_243PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-148	Homo sapiens	blood plasma	148	not applicable	not available	18	Male	not available	Normal	depleted	148	not applicable	RHD01_243PR_2	proteomic profiling by mass spectrometry	RHD01_243PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_243PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-149	Homo sapiens	blood plasma	149	not applicable	not available	29	Male	not available	Normal	depleted	149	not applicable	RHD01_244_1	proteomic profiling by mass spectrometry	RHD01_244_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_244_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-149	Homo sapiens	blood plasma	149	not applicable	not available	29	Male	not available	Normal	depleted	149	not applicable	RHD01_244_2	proteomic profiling by mass spectrometry	RHD01_244_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_244_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-150	Homo sapiens	blood plasma	150	not applicable	not available	41	Female	not available	Rheumatic Heart Disease	depleted	150	not applicable	RHD01_245_1	proteomic profiling by mass spectrometry	RHD01_245_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_245_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-150	Homo sapiens	blood plasma	150	not applicable	not available	41	Female	not available	Rheumatic Heart Disease	depleted	150	not applicable	RHD01_245_2	proteomic profiling by mass spectrometry	RHD01_245_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_245_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-151	Homo sapiens	blood plasma	151	not applicable	not available	30	Male	not available	Normal	depleted	151	not applicable	RHD01_246_1	proteomic profiling by mass spectrometry	RHD01_246_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_246_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-151	Homo sapiens	blood plasma	151	not applicable	not available	30	Male	not available	Normal	depleted	151	not applicable	RHD01_246_2	proteomic profiling by mass spectrometry	RHD01_246_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_246_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-152	Homo sapiens	blood plasma	152	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	152	not applicable	RHD01_247_1	proteomic profiling by mass spectrometry	RHD01_247_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_247_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-152	Homo sapiens	blood plasma	152	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	152	not applicable	RHD01_247_2	proteomic profiling by mass spectrometry	RHD01_247_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_247_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-153	Homo sapiens	blood plasma	153	not applicable	not available	24	Female	not available	Normal	depleted	153	not applicable	RHD01_248_1	proteomic profiling by mass spectrometry	RHD01_248_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_248_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-153	Homo sapiens	blood plasma	153	not applicable	not available	24	Female	not available	Normal	depleted	153	not applicable	RHD01_248_2	proteomic profiling by mass spectrometry	RHD01_248_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_248_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-154	Homo sapiens	blood plasma	154	not applicable	not available	20	Female	not available	Rheumatic Heart Disease	depleted	154	not applicable	RHD01_249PR_1	proteomic profiling by mass spectrometry	RHD01_249PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_249PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-154	Homo sapiens	blood plasma	154	not applicable	not available	20	Female	not available	Rheumatic Heart Disease	depleted	154	not applicable	RHD01_249PR_2	proteomic profiling by mass spectrometry	RHD01_249PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_249PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-155	Homo sapiens	blood plasma	155	not applicable	not available	27	Female	not available	Normal	depleted	155	not applicable	RHD01_24_1	proteomic profiling by mass spectrometry	RHD01_24_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_24_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-155	Homo sapiens	blood plasma	155	not applicable	not available	27	Female	not available	Normal	depleted	155	not applicable	RHD01_24_2	proteomic profiling by mass spectrometry	RHD01_24_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_24_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-156	Homo sapiens	blood plasma	156	not applicable	not available	23	Female	not available	Rheumatic Heart Disease	depleted	156	not applicable	RHD01_250_1	proteomic profiling by mass spectrometry	RHD01_250_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_250_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-156	Homo sapiens	blood plasma	156	not applicable	not available	23	Female	not available	Rheumatic Heart Disease	depleted	156	not applicable	RHD01_250_2	proteomic profiling by mass spectrometry	RHD01_250_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_250_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-157	Homo sapiens	blood plasma	157	not applicable	not available	17	Male	not available	Normal	depleted	157	not applicable	RHD01_251_1	proteomic profiling by mass spectrometry	RHD01_251_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_251_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-157	Homo sapiens	blood plasma	157	not applicable	not available	17	Male	not available	Normal	depleted	157	not applicable	RHD01_251_2	proteomic profiling by mass spectrometry	RHD01_251_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_251_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-158	Homo sapiens	blood plasma	158	not applicable	not available	37	Female	not available	Rheumatic Heart Disease	depleted	158	not applicable	RHD01_252PR_1	proteomic profiling by mass spectrometry	RHD01_252PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_252PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-158	Homo sapiens	blood plasma	158	not applicable	not available	37	Female	not available	Rheumatic Heart Disease	depleted	158	not applicable	RHD01_252PR_2	proteomic profiling by mass spectrometry	RHD01_252PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_252PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-159	Homo sapiens	blood plasma	159	not applicable	not available	26	Female	not available	Rheumatic Heart Disease	depleted	159	not applicable	RHD01_253_1	proteomic profiling by mass spectrometry	RHD01_253_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_253_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-159	Homo sapiens	blood plasma	159	not applicable	not available	26	Female	not available	Rheumatic Heart Disease	depleted	159	not applicable	RHD01_253_2	proteomic profiling by mass spectrometry	RHD01_253_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_253_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-160	Homo sapiens	blood plasma	160	not applicable	not available	28	Female	not available	Normal	depleted	160	not applicable	RHD01_254_1	proteomic profiling by mass spectrometry	RHD01_254_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_254_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-160	Homo sapiens	blood plasma	160	not applicable	not available	28	Female	not available	Normal	depleted	160	not applicable	RHD01_254_2	proteomic profiling by mass spectrometry	RHD01_254_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_254_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-161	Homo sapiens	blood plasma	161	not applicable	not available	49	Female	not available	Normal	depleted	161	not applicable	RHD01_255_1	proteomic profiling by mass spectrometry	RHD01_255_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_255_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-161	Homo sapiens	blood plasma	161	not applicable	not available	49	Female	not available	Normal	depleted	161	not applicable	RHD01_255_2	proteomic profiling by mass spectrometry	RHD01_255_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_255_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-162	Homo sapiens	blood plasma	162	not applicable	not available	28	Female	not available	Normal	depleted	162	not applicable	RHD01_256_1	proteomic profiling by mass spectrometry	RHD01_256_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_256_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-162	Homo sapiens	blood plasma	162	not applicable	not available	28	Female	not available	Normal	depleted	162	not applicable	RHD01_256_2	proteomic profiling by mass spectrometry	RHD01_256_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_256_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-163	Homo sapiens	blood plasma	163	not applicable	not available	30	Male	not available	Rheumatic Heart Disease	depleted	163	not applicable	RHD01_257_1	proteomic profiling by mass spectrometry	RHD01_257_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_257_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-163	Homo sapiens	blood plasma	163	not applicable	not available	30	Male	not available	Rheumatic Heart Disease	depleted	163	not applicable	RHD01_257_2	proteomic profiling by mass spectrometry	RHD01_257_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_257_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-164	Homo sapiens	blood plasma	164	not applicable	not available	34	Female	not available	Normal	depleted	164	not applicable	RHD01_258PR_1	proteomic profiling by mass spectrometry	RHD01_258PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_258PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-164	Homo sapiens	blood plasma	164	not applicable	not available	34	Female	not available	Normal	depleted	164	not applicable	RHD01_258PR_2	proteomic profiling by mass spectrometry	RHD01_258PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_258PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-165	Homo sapiens	blood plasma	165	not applicable	not available	28	Male	not available	Normal	depleted	165	not applicable	RHD01_259_1	proteomic profiling by mass spectrometry	RHD01_259_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_259_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-165	Homo sapiens	blood plasma	165	not applicable	not available	28	Male	not available	Normal	depleted	165	not applicable	RHD01_259_2	proteomic profiling by mass spectrometry	RHD01_259_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_259_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-166	Homo sapiens	blood plasma	166	not applicable	not available	31	Female	not available	Rheumatic Heart Disease	depleted	166	not applicable	RHD01_25_1	proteomic profiling by mass spectrometry	RHD01_25_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_25_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-166	Homo sapiens	blood plasma	166	not applicable	not available	31	Female	not available	Rheumatic Heart Disease	depleted	166	not applicable	RHD01_25_2	proteomic profiling by mass spectrometry	RHD01_25_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_25_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-167	Homo sapiens	blood plasma	167	not applicable	not available	40	Female	not available	Rheumatic Heart Disease	depleted	167	not applicable	RHD01_260_1	proteomic profiling by mass spectrometry	RHD01_260_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_260_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-167	Homo sapiens	blood plasma	167	not applicable	not available	40	Female	not available	Rheumatic Heart Disease	depleted	167	not applicable	RHD01_260_2	proteomic profiling by mass spectrometry	RHD01_260_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_260_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-168	Homo sapiens	blood plasma	168	not applicable	not available	28	Female	not available	Normal	depleted	168	not applicable	RHD01_261_1	proteomic profiling by mass spectrometry	RHD01_261_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_261_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-168	Homo sapiens	blood plasma	168	not applicable	not available	28	Female	not available	Normal	depleted	168	not applicable	RHD01_261_2	proteomic profiling by mass spectrometry	RHD01_261_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_261_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-169	Homo sapiens	blood plasma	169	not applicable	not available	21	Female	not available	Normal	depleted	169	not applicable	RHD01_262_1	proteomic profiling by mass spectrometry	RHD01_262_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_262_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-169	Homo sapiens	blood plasma	169	not applicable	not available	21	Female	not available	Normal	depleted	169	not applicable	RHD01_262_2	proteomic profiling by mass spectrometry	RHD01_262_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_262_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-170	Homo sapiens	blood plasma	170	not applicable	not available	28	Male	not available	Normal	depleted	170	not applicable	RHD01_263PR_1	proteomic profiling by mass spectrometry	RHD01_263PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_263PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-170	Homo sapiens	blood plasma	170	not applicable	not available	28	Male	not available	Normal	depleted	170	not applicable	RHD01_263PR_2	proteomic profiling by mass spectrometry	RHD01_263PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_263PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-171	Homo sapiens	blood plasma	171	not applicable	not available	20	Female	not available	Rheumatic Heart Disease	depleted	171	not applicable	RHD01_264_1	proteomic profiling by mass spectrometry	RHD01_264_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_264_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-171	Homo sapiens	blood plasma	171	not applicable	not available	20	Female	not available	Rheumatic Heart Disease	depleted	171	not applicable	RHD01_264_2	proteomic profiling by mass spectrometry	RHD01_264_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_264_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-172	Homo sapiens	blood plasma	172	not applicable	not available	50	Male	not available	Rheumatic Heart Disease	depleted	172	not applicable	RHD01_265_1	proteomic profiling by mass spectrometry	RHD01_265_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_265_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-172	Homo sapiens	blood plasma	172	not applicable	not available	50	Male	not available	Rheumatic Heart Disease	depleted	172	not applicable	RHD01_265_2	proteomic profiling by mass spectrometry	RHD01_265_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_265_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-173	Homo sapiens	blood plasma	173	not applicable	not available	50	Female	not available	Normal	depleted	173	not applicable	RHD01_266_1	proteomic profiling by mass spectrometry	RHD01_266_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_266_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-173	Homo sapiens	blood plasma	173	not applicable	not available	50	Female	not available	Normal	depleted	173	not applicable	RHD01_266_2	proteomic profiling by mass spectrometry	RHD01_266_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_266_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-174	Homo sapiens	blood plasma	174	not applicable	not available	28	Male	not available	Rheumatic Heart Disease	depleted	174	not applicable	RHD01_267_1	proteomic profiling by mass spectrometry	RHD01_267_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_267_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-174	Homo sapiens	blood plasma	174	not applicable	not available	28	Male	not available	Rheumatic Heart Disease	depleted	174	not applicable	RHD01_267_2	proteomic profiling by mass spectrometry	RHD01_267_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_267_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-175	Homo sapiens	blood plasma	175	not applicable	not available	76	Female	not available	Rheumatic Heart Disease	depleted	175	not applicable	RHD01_268_1	proteomic profiling by mass spectrometry	RHD01_268_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_268_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-175	Homo sapiens	blood plasma	175	not applicable	not available	76	Female	not available	Rheumatic Heart Disease	depleted	175	not applicable	RHD01_268_2	proteomic profiling by mass spectrometry	RHD01_268_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_268_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-176	Homo sapiens	blood plasma	176	not applicable	not available	48	Female	not available	Normal	depleted	176	not applicable	RHD01_269_1	proteomic profiling by mass spectrometry	RHD01_269_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_269_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-176	Homo sapiens	blood plasma	176	not applicable	not available	48	Female	not available	Normal	depleted	176	not applicable	RHD01_269_2	proteomic profiling by mass spectrometry	RHD01_269_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_269_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-177	Homo sapiens	blood plasma	177	not applicable	not available	32	Male	not available	Normal	depleted	177	not applicable	RHD01_26_1	proteomic profiling by mass spectrometry	RHD01_26_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_26_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-177	Homo sapiens	blood plasma	177	not applicable	not available	32	Male	not available	Normal	depleted	177	not applicable	RHD01_26_2	proteomic profiling by mass spectrometry	RHD01_26_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_26_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-178	Homo sapiens	blood plasma	178	not applicable	not available	7	Female	not available	Rheumatic Heart Disease	depleted	178	not applicable	RHD01_270_1	proteomic profiling by mass spectrometry	RHD01_270_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_270_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-178	Homo sapiens	blood plasma	178	not applicable	not available	7	Female	not available	Rheumatic Heart Disease	depleted	178	not applicable	RHD01_270_2	proteomic profiling by mass spectrometry	RHD01_270_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_270_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-179	Homo sapiens	blood plasma	179	not applicable	not available	46	Female	not available	Normal	depleted	179	not applicable	RHD01_271_1	proteomic profiling by mass spectrometry	RHD01_271_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_271_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-179	Homo sapiens	blood plasma	179	not applicable	not available	46	Female	not available	Normal	depleted	179	not applicable	RHD01_271_2	proteomic profiling by mass spectrometry	RHD01_271_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_271_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-180	Homo sapiens	blood plasma	180	not applicable	not available	26	Male	not available	Normal	depleted	180	not applicable	RHD01_272_1	proteomic profiling by mass spectrometry	RHD01_272_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_272_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-180	Homo sapiens	blood plasma	180	not applicable	not available	26	Male	not available	Normal	depleted	180	not applicable	RHD01_272_2	proteomic profiling by mass spectrometry	RHD01_272_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_272_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-181	Homo sapiens	blood plasma	181	not applicable	not available	48	Male	not available	Rheumatic Heart Disease	depleted	181	not applicable	RHD01_273_1	proteomic profiling by mass spectrometry	RHD01_273_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_273_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-181	Homo sapiens	blood plasma	181	not applicable	not available	48	Male	not available	Rheumatic Heart Disease	depleted	181	not applicable	RHD01_273_2	proteomic profiling by mass spectrometry	RHD01_273_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_273_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-182	Homo sapiens	blood plasma	182	not applicable	not available	18	Male	not available	Normal	depleted	182	not applicable	RHD01_274_1	proteomic profiling by mass spectrometry	RHD01_274_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_274_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-182	Homo sapiens	blood plasma	182	not applicable	not available	18	Male	not available	Normal	depleted	182	not applicable	RHD01_274_2	proteomic profiling by mass spectrometry	RHD01_274_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_274_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-183	Homo sapiens	blood plasma	183	not applicable	not available	47	Female	not available	Normal	depleted	183	not applicable	RHD01_275_1	proteomic profiling by mass spectrometry	RHD01_275_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_275_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-183	Homo sapiens	blood plasma	183	not applicable	not available	47	Female	not available	Normal	depleted	183	not applicable	RHD01_275_2	proteomic profiling by mass spectrometry	RHD01_275_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_275_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-184	Homo sapiens	blood plasma	184	not applicable	not available	25	Male	not available	Normal	depleted	184	not applicable	RHD01_276_1	proteomic profiling by mass spectrometry	RHD01_276_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_276_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-184	Homo sapiens	blood plasma	184	not applicable	not available	25	Male	not available	Normal	depleted	184	not applicable	RHD01_276_2	proteomic profiling by mass spectrometry	RHD01_276_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_276_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-185	Homo sapiens	blood plasma	185	not applicable	not available	24	Female	not available	Normal	depleted	185	not applicable	RHD01_277_1	proteomic profiling by mass spectrometry	RHD01_277_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_277_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-185	Homo sapiens	blood plasma	185	not applicable	not available	24	Female	not available	Normal	depleted	185	not applicable	RHD01_277_2	proteomic profiling by mass spectrometry	RHD01_277_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_277_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-186	Homo sapiens	blood plasma	186	not applicable	not available	21	Male	not available	Rheumatic Heart Disease	depleted	186	not applicable	RHD01_278_1	proteomic profiling by mass spectrometry	RHD01_278_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_278_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-186	Homo sapiens	blood plasma	186	not applicable	not available	21	Male	not available	Rheumatic Heart Disease	depleted	186	not applicable	RHD01_278_2	proteomic profiling by mass spectrometry	RHD01_278_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_278_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-187	Homo sapiens	blood plasma	187	not applicable	not available	56	Female	not available	Rheumatic Heart Disease	depleted	187	not applicable	RHD01_279_1	proteomic profiling by mass spectrometry	RHD01_279_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_279_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-187	Homo sapiens	blood plasma	187	not applicable	not available	56	Female	not available	Rheumatic Heart Disease	depleted	187	not applicable	RHD01_279_2	proteomic profiling by mass spectrometry	RHD01_279_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_279_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-188	Homo sapiens	blood plasma	188	not applicable	not available	22	Male	not available	Normal	depleted	188	not applicable	RHD01_27_1	proteomic profiling by mass spectrometry	RHD01_27_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_27_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-188	Homo sapiens	blood plasma	188	not applicable	not available	22	Male	not available	Normal	depleted	188	not applicable	RHD01_27_2	proteomic profiling by mass spectrometry	RHD01_27_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_27_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-189	Homo sapiens	blood plasma	189	not applicable	not available	26	Female	not available	Normal	depleted	189	not applicable	RHD01_280_1	proteomic profiling by mass spectrometry	RHD01_280_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_280_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-189	Homo sapiens	blood plasma	189	not applicable	not available	26	Female	not available	Normal	depleted	189	not applicable	RHD01_280_2	proteomic profiling by mass spectrometry	RHD01_280_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_280_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-190	Homo sapiens	blood plasma	190	not applicable	not available	45	Female	not available	Rheumatic Heart Disease	depleted	190	not applicable	RHD01_281_1	proteomic profiling by mass spectrometry	RHD01_281_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_281_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-190	Homo sapiens	blood plasma	190	not applicable	not available	45	Female	not available	Rheumatic Heart Disease	depleted	190	not applicable	RHD01_281_2	proteomic profiling by mass spectrometry	RHD01_281_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_281_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-191	Homo sapiens	blood plasma	191	not applicable	not available	14	Male	not available	Rheumatic Heart Disease	depleted	191	not applicable	RHD01_282_1	proteomic profiling by mass spectrometry	RHD01_282_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_282_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-191	Homo sapiens	blood plasma	191	not applicable	not available	14	Male	not available	Rheumatic Heart Disease	depleted	191	not applicable	RHD01_282_2	proteomic profiling by mass spectrometry	RHD01_282_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_282_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-192	Homo sapiens	blood plasma	192	not applicable	not available	12	Female	not available	Rheumatic Heart Disease	depleted	192	not applicable	RHD01_283_1	proteomic profiling by mass spectrometry	RHD01_283_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_283_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-192	Homo sapiens	blood plasma	192	not applicable	not available	12	Female	not available	Rheumatic Heart Disease	depleted	192	not applicable	RHD01_283_2	proteomic profiling by mass spectrometry	RHD01_283_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_283_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-193	Homo sapiens	blood plasma	193	not applicable	not available	4	Male	not available	Rheumatic Heart Disease	depleted	193	not applicable	RHD01_284_1	proteomic profiling by mass spectrometry	RHD01_284_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_284_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-193	Homo sapiens	blood plasma	193	not applicable	not available	4	Male	not available	Rheumatic Heart Disease	depleted	193	not applicable	RHD01_284_2	proteomic profiling by mass spectrometry	RHD01_284_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_284_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-194	Homo sapiens	blood plasma	194	not applicable	not available	21	Female	not available	Rheumatic Heart Disease	depleted	194	not applicable	RHD01_285_1	proteomic profiling by mass spectrometry	RHD01_285_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_285_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-194	Homo sapiens	blood plasma	194	not applicable	not available	21	Female	not available	Rheumatic Heart Disease	depleted	194	not applicable	RHD01_285_2	proteomic profiling by mass spectrometry	RHD01_285_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_285_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-195	Homo sapiens	blood plasma	195	not applicable	not available	56	Female	not available	Rheumatic Heart Disease	depleted	195	not applicable	RHD01_286_1	proteomic profiling by mass spectrometry	RHD01_286_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_286_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-195	Homo sapiens	blood plasma	195	not applicable	not available	56	Female	not available	Rheumatic Heart Disease	depleted	195	not applicable	RHD01_286_2	proteomic profiling by mass spectrometry	RHD01_286_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_286_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-196	Homo sapiens	blood plasma	196	not applicable	not available	31	Female	not available	Rheumatic Heart Disease	depleted	196	not applicable	RHD01_287_1	proteomic profiling by mass spectrometry	RHD01_287_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_287_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-196	Homo sapiens	blood plasma	196	not applicable	not available	31	Female	not available	Rheumatic Heart Disease	depleted	196	not applicable	RHD01_287_2	proteomic profiling by mass spectrometry	RHD01_287_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_287_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-197	Homo sapiens	blood plasma	197	not applicable	not available	41	Female	not available	Rheumatic Heart Disease	depleted	197	not applicable	RHD01_288_1	proteomic profiling by mass spectrometry	RHD01_288_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_288_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-197	Homo sapiens	blood plasma	197	not applicable	not available	41	Female	not available	Rheumatic Heart Disease	depleted	197	not applicable	RHD01_288_2	proteomic profiling by mass spectrometry	RHD01_288_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_288_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-198	Homo sapiens	blood plasma	198	not applicable	not available	64	Female	not available	Rheumatic Heart Disease	depleted	198	not applicable	RHD01_289_1	proteomic profiling by mass spectrometry	RHD01_289_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_289_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-198	Homo sapiens	blood plasma	198	not applicable	not available	64	Female	not available	Rheumatic Heart Disease	depleted	198	not applicable	RHD01_289_2	proteomic profiling by mass spectrometry	RHD01_289_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_289_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-199	Homo sapiens	blood plasma	199	not applicable	not available	34	Female	not available	Rheumatic Heart Disease	depleted	199	not applicable	RHD01_28_1	proteomic profiling by mass spectrometry	RHD01_28_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_28_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-199	Homo sapiens	blood plasma	199	not applicable	not available	34	Female	not available	Rheumatic Heart Disease	depleted	199	not applicable	RHD01_28_2	proteomic profiling by mass spectrometry	RHD01_28_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_28_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-200	Homo sapiens	blood plasma	200	not applicable	not available	37	Female	not available	Normal	depleted	200	not applicable	RHD01_290_1	proteomic profiling by mass spectrometry	RHD01_290_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_290_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-200	Homo sapiens	blood plasma	200	not applicable	not available	37	Female	not available	Normal	depleted	200	not applicable	RHD01_290_2	proteomic profiling by mass spectrometry	RHD01_290_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_290_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-201	Homo sapiens	blood plasma	201	not applicable	not available	30	Female	not available	Normal	depleted	201	not applicable	RHD01_291_1	proteomic profiling by mass spectrometry	RHD01_291_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_291_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-201	Homo sapiens	blood plasma	201	not applicable	not available	30	Female	not available	Normal	depleted	201	not applicable	RHD01_291_2	proteomic profiling by mass spectrometry	RHD01_291_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_291_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-202	Homo sapiens	blood plasma	202	not applicable	not available	24	Female	not available	Normal	depleted	202	not applicable	RHD01_292PR_1	proteomic profiling by mass spectrometry	RHD01_292PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_292PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-202	Homo sapiens	blood plasma	202	not applicable	not available	24	Female	not available	Normal	depleted	202	not applicable	RHD01_292PR_2	proteomic profiling by mass spectrometry	RHD01_292PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_292PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-203	Homo sapiens	blood plasma	203	not applicable	not available	53	Male	not available	Normal	depleted	203	not applicable	RHD01_293_1	proteomic profiling by mass spectrometry	RHD01_293_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_293_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-203	Homo sapiens	blood plasma	203	not applicable	not available	53	Male	not available	Normal	depleted	203	not applicable	RHD01_293_2	proteomic profiling by mass spectrometry	RHD01_293_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_293_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-204	Homo sapiens	blood plasma	204	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	204	not applicable	RHD01_294_1	proteomic profiling by mass spectrometry	RHD01_294_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_294_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-204	Homo sapiens	blood plasma	204	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	204	not applicable	RHD01_294_2	proteomic profiling by mass spectrometry	RHD01_294_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_294_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-205	Homo sapiens	blood plasma	205	not applicable	not available	33	Male	not available	Normal	depleted	205	not applicable	RHD01_296_1	proteomic profiling by mass spectrometry	RHD01_296_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_296_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-205	Homo sapiens	blood plasma	205	not applicable	not available	33	Male	not available	Normal	depleted	205	not applicable	RHD01_296_2	proteomic profiling by mass spectrometry	RHD01_296_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_296_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-206	Homo sapiens	blood plasma	206	not applicable	not available	9	Male	not available	Rheumatic Heart Disease	depleted	206	not applicable	RHD01_297_1	proteomic profiling by mass spectrometry	RHD01_297_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_297_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-206	Homo sapiens	blood plasma	206	not applicable	not available	9	Male	not available	Rheumatic Heart Disease	depleted	206	not applicable	RHD01_297_2	proteomic profiling by mass spectrometry	RHD01_297_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_297_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-207	Homo sapiens	blood plasma	207	not applicable	not available	30	Female	not available	Normal	depleted	207	not applicable	RHD01_298_1	proteomic profiling by mass spectrometry	RHD01_298_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_298_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-207	Homo sapiens	blood plasma	207	not applicable	not available	30	Female	not available	Normal	depleted	207	not applicable	RHD01_298_2	proteomic profiling by mass spectrometry	RHD01_298_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_298_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-208	Homo sapiens	blood plasma	208	not applicable	not available	20	Male	not available	Normal	depleted	208	not applicable	RHD01_299_1	proteomic profiling by mass spectrometry	RHD01_299_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_299_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-208	Homo sapiens	blood plasma	208	not applicable	not available	20	Male	not available	Normal	depleted	208	not applicable	RHD01_299_2	proteomic profiling by mass spectrometry	RHD01_299_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_299_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-209	Homo sapiens	blood plasma	209	not applicable	not available	20	Male	not available	Normal	depleted	209	not applicable	RHD01_29PR_1	proteomic profiling by mass spectrometry	RHD01_29PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_29PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-209	Homo sapiens	blood plasma	209	not applicable	not available	20	Male	not available	Normal	depleted	209	not applicable	RHD01_29PR_2	proteomic profiling by mass spectrometry	RHD01_29PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_29PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-210	Homo sapiens	blood plasma	210	not applicable	not available	68	Female	not available	Rheumatic Heart Disease	depleted	210	not applicable	RHD01_2_1	proteomic profiling by mass spectrometry	RHD01_2_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_2_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-210	Homo sapiens	blood plasma	210	not applicable	not available	68	Female	not available	Rheumatic Heart Disease	depleted	210	not applicable	RHD01_2_2	proteomic profiling by mass spectrometry	RHD01_2_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_2_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-211	Homo sapiens	blood plasma	211	not applicable	not available	39	Female	not available	Rheumatic Heart Disease	depleted	211	not applicable	RHD01_300_1	proteomic profiling by mass spectrometry	RHD01_300_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_300_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-211	Homo sapiens	blood plasma	211	not applicable	not available	39	Female	not available	Rheumatic Heart Disease	depleted	211	not applicable	RHD01_300_2	proteomic profiling by mass spectrometry	RHD01_300_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_300_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-212	Homo sapiens	blood plasma	212	not applicable	not available	78	Male	not available	Normal	depleted	212	not applicable	RHD01_303_1	proteomic profiling by mass spectrometry	RHD01_303_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_303_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-212	Homo sapiens	blood plasma	212	not applicable	not available	78	Male	not available	Normal	depleted	212	not applicable	RHD01_303_2	proteomic profiling by mass spectrometry	RHD01_303_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_303_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-213	Homo sapiens	blood plasma	213	not applicable	not available	44	Female	not available	Rheumatic Heart Disease	depleted	213	not applicable	RHD01_304_1	proteomic profiling by mass spectrometry	RHD01_304_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_304_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-213	Homo sapiens	blood plasma	213	not applicable	not available	44	Female	not available	Rheumatic Heart Disease	depleted	213	not applicable	RHD01_304_2	proteomic profiling by mass spectrometry	RHD01_304_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_304_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-214	Homo sapiens	blood plasma	214	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	214	not applicable	RHD01_305_1	proteomic profiling by mass spectrometry	RHD01_305_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_305_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-214	Homo sapiens	blood plasma	214	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	214	not applicable	RHD01_305_2	proteomic profiling by mass spectrometry	RHD01_305_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_305_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-215	Homo sapiens	blood plasma	215	not applicable	not available	27	Male	not available	Normal	depleted	215	not applicable	RHD01_306_1	proteomic profiling by mass spectrometry	RHD01_306_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_306_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-215	Homo sapiens	blood plasma	215	not applicable	not available	27	Male	not available	Normal	depleted	215	not applicable	RHD01_306_2	proteomic profiling by mass spectrometry	RHD01_306_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_306_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-216	Homo sapiens	blood plasma	216	not applicable	not available	21	Female	not available	Normal	depleted	216	not applicable	RHD01_307_1	proteomic profiling by mass spectrometry	RHD01_307_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_307_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-216	Homo sapiens	blood plasma	216	not applicable	not available	21	Female	not available	Normal	depleted	216	not applicable	RHD01_307_2	proteomic profiling by mass spectrometry	RHD01_307_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_307_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-217	Homo sapiens	blood plasma	217	not applicable	not available	24	Female	not available	Rheumatic Heart Disease	depleted	217	not applicable	RHD01_308_1	proteomic profiling by mass spectrometry	RHD01_308_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_308_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-217	Homo sapiens	blood plasma	217	not applicable	not available	24	Female	not available	Rheumatic Heart Disease	depleted	217	not applicable	RHD01_308_2	proteomic profiling by mass spectrometry	RHD01_308_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_308_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-218	Homo sapiens	blood plasma	218	not applicable	not available	38	Female	not available	Normal	depleted	218	not applicable	RHD01_309_1	proteomic profiling by mass spectrometry	RHD01_309_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_309_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-218	Homo sapiens	blood plasma	218	not applicable	not available	38	Female	not available	Normal	depleted	218	not applicable	RHD01_309_2	proteomic profiling by mass spectrometry	RHD01_309_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_309_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-219	Homo sapiens	blood plasma	219	not applicable	not available	37	Male	not available	Normal	depleted	219	not applicable	RHD01_30_1	proteomic profiling by mass spectrometry	RHD01_30_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_30_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-219	Homo sapiens	blood plasma	219	not applicable	not available	37	Male	not available	Normal	depleted	219	not applicable	RHD01_30_2	proteomic profiling by mass spectrometry	RHD01_30_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_30_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-220	Homo sapiens	blood plasma	220	not applicable	not available	29	Female	not available	Normal	depleted	220	not applicable	RHD01_310_1	proteomic profiling by mass spectrometry	RHD01_310_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_310_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-220	Homo sapiens	blood plasma	220	not applicable	not available	29	Female	not available	Normal	depleted	220	not applicable	RHD01_310_2	proteomic profiling by mass spectrometry	RHD01_310_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_310_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-221	Homo sapiens	blood plasma	221	not applicable	not available	43	Female	not available	Normal	depleted	221	not applicable	RHD01_311_1	proteomic profiling by mass spectrometry	RHD01_311_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_311_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-221	Homo sapiens	blood plasma	221	not applicable	not available	43	Female	not available	Normal	depleted	221	not applicable	RHD01_311_2	proteomic profiling by mass spectrometry	RHD01_311_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_311_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-222	Homo sapiens	blood plasma	222	not applicable	not available	10	Female	not available	Rheumatic Heart Disease	depleted	222	not applicable	RHD01_312_1	proteomic profiling by mass spectrometry	RHD01_312_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_312_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-222	Homo sapiens	blood plasma	222	not applicable	not available	10	Female	not available	Rheumatic Heart Disease	depleted	222	not applicable	RHD01_312_2	proteomic profiling by mass spectrometry	RHD01_312_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_312_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-223	Homo sapiens	blood plasma	223	not applicable	not available	15	Male	not available	Rheumatic Heart Disease	depleted	223	not applicable	RHD01_313_1	proteomic profiling by mass spectrometry	RHD01_313_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_313_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-223	Homo sapiens	blood plasma	223	not applicable	not available	15	Male	not available	Rheumatic Heart Disease	depleted	223	not applicable	RHD01_313_2	proteomic profiling by mass spectrometry	RHD01_313_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_313_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-224	Homo sapiens	blood plasma	224	not applicable	not available	15	Male	not available	Rheumatic Heart Disease	depleted	224	not applicable	RHD01_314PR_1	proteomic profiling by mass spectrometry	RHD01_314PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_314PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-224	Homo sapiens	blood plasma	224	not applicable	not available	15	Male	not available	Rheumatic Heart Disease	depleted	224	not applicable	RHD01_314PR_2	proteomic profiling by mass spectrometry	RHD01_314PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_314PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-225	Homo sapiens	blood plasma	225	not applicable	not available	25	Female	not available	Normal	depleted	225	not applicable	RHD01_315_1	proteomic profiling by mass spectrometry	RHD01_315_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_315_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-225	Homo sapiens	blood plasma	225	not applicable	not available	25	Female	not available	Normal	depleted	225	not applicable	RHD01_315_2	proteomic profiling by mass spectrometry	RHD01_315_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_315_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-226	Homo sapiens	blood plasma	226	not applicable	not available	28	Female	not available	Normal	depleted	226	not applicable	RHD01_316_1	proteomic profiling by mass spectrometry	RHD01_316_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_316_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-226	Homo sapiens	blood plasma	226	not applicable	not available	28	Female	not available	Normal	depleted	226	not applicable	RHD01_316_2	proteomic profiling by mass spectrometry	RHD01_316_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_316_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-227	Homo sapiens	blood plasma	227	not applicable	not available	32	Female	not available	Rheumatic Heart Disease	depleted	227	not applicable	RHD01_317_1	proteomic profiling by mass spectrometry	RHD01_317_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_317_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-227	Homo sapiens	blood plasma	227	not applicable	not available	32	Female	not available	Rheumatic Heart Disease	depleted	227	not applicable	RHD01_317_2	proteomic profiling by mass spectrometry	RHD01_317_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_317_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-228	Homo sapiens	blood plasma	228	not applicable	not available	49	Female	not available	Rheumatic Heart Disease	depleted	228	not applicable	RHD01_318_1	proteomic profiling by mass spectrometry	RHD01_318_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_318_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-228	Homo sapiens	blood plasma	228	not applicable	not available	49	Female	not available	Rheumatic Heart Disease	depleted	228	not applicable	RHD01_318_2	proteomic profiling by mass spectrometry	RHD01_318_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_318_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-229	Homo sapiens	blood plasma	229	not applicable	not available	35	Male	not available	Rheumatic Heart Disease	depleted	229	not applicable	RHD01_319_1	proteomic profiling by mass spectrometry	RHD01_319_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_319_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-229	Homo sapiens	blood plasma	229	not applicable	not available	35	Male	not available	Rheumatic Heart Disease	depleted	229	not applicable	RHD01_319_2	proteomic profiling by mass spectrometry	RHD01_319_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_319_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-230	Homo sapiens	blood plasma	230	not applicable	not available	10	Female	not available	Rheumatic Heart Disease	depleted	230	not applicable	RHD01_31_1	proteomic profiling by mass spectrometry	RHD01_31_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_31_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-230	Homo sapiens	blood plasma	230	not applicable	not available	10	Female	not available	Rheumatic Heart Disease	depleted	230	not applicable	RHD01_31_2	proteomic profiling by mass spectrometry	RHD01_31_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_31_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-231	Homo sapiens	blood plasma	231	not applicable	not available	57	Female	not available	Normal	depleted	231	not applicable	RHD01_320_1	proteomic profiling by mass spectrometry	RHD01_320_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_320_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-231	Homo sapiens	blood plasma	231	not applicable	not available	57	Female	not available	Normal	depleted	231	not applicable	RHD01_320_2	proteomic profiling by mass spectrometry	RHD01_320_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_320_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-232	Homo sapiens	blood plasma	232	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	232	not applicable	RHD01_322_1	proteomic profiling by mass spectrometry	RHD01_322_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_322_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-232	Homo sapiens	blood plasma	232	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	232	not applicable	RHD01_322_2	proteomic profiling by mass spectrometry	RHD01_322_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_322_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-233	Homo sapiens	blood plasma	233	not applicable	not available	47	Female	not available	Rheumatic Heart Disease	depleted	233	not applicable	RHD01_323_1	proteomic profiling by mass spectrometry	RHD01_323_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_323_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-233	Homo sapiens	blood plasma	233	not applicable	not available	47	Female	not available	Rheumatic Heart Disease	depleted	233	not applicable	RHD01_323_2	proteomic profiling by mass spectrometry	RHD01_323_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_323_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-234	Homo sapiens	blood plasma	234	not applicable	not available	21	Male	not available	Normal	depleted	234	not applicable	RHD01_324_1	proteomic profiling by mass spectrometry	RHD01_324_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_324_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-234	Homo sapiens	blood plasma	234	not applicable	not available	21	Male	not available	Normal	depleted	234	not applicable	RHD01_324_2	proteomic profiling by mass spectrometry	RHD01_324_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_324_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-235	Homo sapiens	blood plasma	235	not applicable	not available	30	Female	not available	Normal	depleted	235	not applicable	RHD01_325_1	proteomic profiling by mass spectrometry	RHD01_325_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_325_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-235	Homo sapiens	blood plasma	235	not applicable	not available	30	Female	not available	Normal	depleted	235	not applicable	RHD01_325_2	proteomic profiling by mass spectrometry	RHD01_325_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_325_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-236	Homo sapiens	blood plasma	236	not applicable	not available	20	Female	not available	Normal	depleted	236	not applicable	RHD01_326_1	proteomic profiling by mass spectrometry	RHD01_326_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_326_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-236	Homo sapiens	blood plasma	236	not applicable	not available	20	Female	not available	Normal	depleted	236	not applicable	RHD01_326_2	proteomic profiling by mass spectrometry	RHD01_326_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_326_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-237	Homo sapiens	blood plasma	237	not applicable	not available	41	Female	not available	Normal	depleted	237	not applicable	RHD01_327_1	proteomic profiling by mass spectrometry	RHD01_327_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_327_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-237	Homo sapiens	blood plasma	237	not applicable	not available	41	Female	not available	Normal	depleted	237	not applicable	RHD01_327_2	proteomic profiling by mass spectrometry	RHD01_327_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_327_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-238	Homo sapiens	blood plasma	238	not applicable	not available	49	Male	not available	Normal	depleted	238	not applicable	RHD01_328_1	proteomic profiling by mass spectrometry	RHD01_328_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_328_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-238	Homo sapiens	blood plasma	238	not applicable	not available	49	Male	not available	Normal	depleted	238	not applicable	RHD01_328_2	proteomic profiling by mass spectrometry	RHD01_328_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_328_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-239	Homo sapiens	blood plasma	239	not applicable	not available	21	Male	not available	Normal	depleted	239	not applicable	RHD01_329_1	proteomic profiling by mass spectrometry	RHD01_329_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_329_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-239	Homo sapiens	blood plasma	239	not applicable	not available	21	Male	not available	Normal	depleted	239	not applicable	RHD01_329_2	proteomic profiling by mass spectrometry	RHD01_329_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_329_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-240	Homo sapiens	blood plasma	240	not applicable	not available	41	Male	not available	Normal	depleted	240	not applicable	RHD01_32_1	proteomic profiling by mass spectrometry	RHD01_32_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_32_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-240	Homo sapiens	blood plasma	240	not applicable	not available	41	Male	not available	Normal	depleted	240	not applicable	RHD01_32_2	proteomic profiling by mass spectrometry	RHD01_32_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_32_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-241	Homo sapiens	blood plasma	241	not applicable	not available	25	Female	not available	Rheumatic Heart Disease	depleted	241	not applicable	RHD01_330_1	proteomic profiling by mass spectrometry	RHD01_330_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_330_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-241	Homo sapiens	blood plasma	241	not applicable	not available	25	Female	not available	Rheumatic Heart Disease	depleted	241	not applicable	RHD01_330_2	proteomic profiling by mass spectrometry	RHD01_330_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_330_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-242	Homo sapiens	blood plasma	242	not applicable	not available	10	Male	not available	Rheumatic Heart Disease	depleted	242	not applicable	RHD01_331_1	proteomic profiling by mass spectrometry	RHD01_331_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_331_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-242	Homo sapiens	blood plasma	242	not applicable	not available	10	Male	not available	Rheumatic Heart Disease	depleted	242	not applicable	RHD01_331_2	proteomic profiling by mass spectrometry	RHD01_331_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_331_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-243	Homo sapiens	blood plasma	243	not applicable	not available	31	Female	not available	Normal	depleted	243	not applicable	RHD01_332_1	proteomic profiling by mass spectrometry	RHD01_332_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_332_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-243	Homo sapiens	blood plasma	243	not applicable	not available	31	Female	not available	Normal	depleted	243	not applicable	RHD01_332_2	proteomic profiling by mass spectrometry	RHD01_332_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_332_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-244	Homo sapiens	blood plasma	244	not applicable	not available	19	Male	not available	Rheumatic Heart Disease	depleted	244	not applicable	RHD01_333_1	proteomic profiling by mass spectrometry	RHD01_333_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_333_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-244	Homo sapiens	blood plasma	244	not applicable	not available	19	Male	not available	Rheumatic Heart Disease	depleted	244	not applicable	RHD01_333_2	proteomic profiling by mass spectrometry	RHD01_333_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_333_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-245	Homo sapiens	blood plasma	245	not applicable	not available	19	Male	not available	Rheumatic Heart Disease	depleted	245	not applicable	RHD01_334PR_1	proteomic profiling by mass spectrometry	RHD01_334PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_334PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-245	Homo sapiens	blood plasma	245	not applicable	not available	19	Male	not available	Rheumatic Heart Disease	depleted	245	not applicable	RHD01_334PR_2	proteomic profiling by mass spectrometry	RHD01_334PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_334PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-246	Homo sapiens	blood plasma	246	not applicable	not available	19	Female	not available	Rheumatic Heart Disease	depleted	246	not applicable	RHD01_335_1	proteomic profiling by mass spectrometry	RHD01_335_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_335_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-246	Homo sapiens	blood plasma	246	not applicable	not available	19	Female	not available	Rheumatic Heart Disease	depleted	246	not applicable	RHD01_335_2	proteomic profiling by mass spectrometry	RHD01_335_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_335_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-247	Homo sapiens	blood plasma	247	not applicable	not available	26	Female	not available	Normal	depleted	247	not applicable	RHD01_336_1	proteomic profiling by mass spectrometry	RHD01_336_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_336_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-247	Homo sapiens	blood plasma	247	not applicable	not available	26	Female	not available	Normal	depleted	247	not applicable	RHD01_336_2	proteomic profiling by mass spectrometry	RHD01_336_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_336_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-248	Homo sapiens	blood plasma	248	not applicable	not available	29	Female	not available	Normal	depleted	248	not applicable	RHD01_337_1	proteomic profiling by mass spectrometry	RHD01_337_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_337_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-248	Homo sapiens	blood plasma	248	not applicable	not available	29	Female	not available	Normal	depleted	248	not applicable	RHD01_337_2	proteomic profiling by mass spectrometry	RHD01_337_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_337_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-249	Homo sapiens	blood plasma	249	not applicable	not available	17	Male	not available	Normal	depleted	249	not applicable	RHD01_338_1	proteomic profiling by mass spectrometry	RHD01_338_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_338_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-249	Homo sapiens	blood plasma	249	not applicable	not available	17	Male	not available	Normal	depleted	249	not applicable	RHD01_338_2	proteomic profiling by mass spectrometry	RHD01_338_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_338_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-250	Homo sapiens	blood plasma	250	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	250	not applicable	RHD01_339PR_1	proteomic profiling by mass spectrometry	RHD01_339PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_339PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-250	Homo sapiens	blood plasma	250	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	250	not applicable	RHD01_339PR_2	proteomic profiling by mass spectrometry	RHD01_339PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_339PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-251	Homo sapiens	blood plasma	251	not applicable	not available	22	Female	not available	Normal	depleted	251	not applicable	RHD01_33_1	proteomic profiling by mass spectrometry	RHD01_33_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_33_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-251	Homo sapiens	blood plasma	251	not applicable	not available	22	Female	not available	Normal	depleted	251	not applicable	RHD01_33_2	proteomic profiling by mass spectrometry	RHD01_33_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_33_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-252	Homo sapiens	blood plasma	252	not applicable	not available	69	Male	not available	Rheumatic Heart Disease	depleted	252	not applicable	RHD01_340_1	proteomic profiling by mass spectrometry	RHD01_340_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_340_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-252	Homo sapiens	blood plasma	252	not applicable	not available	69	Male	not available	Rheumatic Heart Disease	depleted	252	not applicable	RHD01_340_2	proteomic profiling by mass spectrometry	RHD01_340_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_340_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-253	Homo sapiens	blood plasma	253	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	253	not applicable	RHD01_341_1	proteomic profiling by mass spectrometry	RHD01_341_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_341_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-253	Homo sapiens	blood plasma	253	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	253	not applicable	RHD01_341_2	proteomic profiling by mass spectrometry	RHD01_341_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_341_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-254	Homo sapiens	blood plasma	254	not applicable	not available	60	Female	not available	Normal	depleted	254	not applicable	RHD01_342_1	proteomic profiling by mass spectrometry	RHD01_342_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_342_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-254	Homo sapiens	blood plasma	254	not applicable	not available	60	Female	not available	Normal	depleted	254	not applicable	RHD01_342_2	proteomic profiling by mass spectrometry	RHD01_342_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_342_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-255	Homo sapiens	blood plasma	255	not applicable	not available	8	Female	not available	Rheumatic Heart Disease	depleted	255	not applicable	RHD01_343_1	proteomic profiling by mass spectrometry	RHD01_343_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_343_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-255	Homo sapiens	blood plasma	255	not applicable	not available	8	Female	not available	Rheumatic Heart Disease	depleted	255	not applicable	RHD01_343_2	proteomic profiling by mass spectrometry	RHD01_343_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_343_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-256	Homo sapiens	blood plasma	256	not applicable	not available	9	Female	not available	Rheumatic Heart Disease	depleted	256	not applicable	RHD01_344_1	proteomic profiling by mass spectrometry	RHD01_344_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_344_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-256	Homo sapiens	blood plasma	256	not applicable	not available	9	Female	not available	Rheumatic Heart Disease	depleted	256	not applicable	RHD01_344_2	proteomic profiling by mass spectrometry	RHD01_344_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_344_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-257	Homo sapiens	blood plasma	257	not applicable	not available	16	Male	not available	Normal	depleted	257	not applicable	RHD01_345_1	proteomic profiling by mass spectrometry	RHD01_345_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_345_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-257	Homo sapiens	blood plasma	257	not applicable	not available	16	Male	not available	Normal	depleted	257	not applicable	RHD01_345_2	proteomic profiling by mass spectrometry	RHD01_345_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_345_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-258	Homo sapiens	blood plasma	258	not applicable	not available	22	Female	not available	Normal	depleted	258	not applicable	RHD01_346_1	proteomic profiling by mass spectrometry	RHD01_346_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_346_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-258	Homo sapiens	blood plasma	258	not applicable	not available	22	Female	not available	Normal	depleted	258	not applicable	RHD01_346_2	proteomic profiling by mass spectrometry	RHD01_346_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_346_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-259	Homo sapiens	blood plasma	259	not applicable	not available	24	Female	not available	Normal	depleted	259	not applicable	RHD01_347_1	proteomic profiling by mass spectrometry	RHD01_347_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_347_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-259	Homo sapiens	blood plasma	259	not applicable	not available	24	Female	not available	Normal	depleted	259	not applicable	RHD01_347_2	proteomic profiling by mass spectrometry	RHD01_347_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_347_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-260	Homo sapiens	blood plasma	260	not applicable	not available	24	Female	not available	Normal	depleted	260	not applicable	RHD01_348_1	proteomic profiling by mass spectrometry	RHD01_348_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_348_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-260	Homo sapiens	blood plasma	260	not applicable	not available	24	Female	not available	Normal	depleted	260	not applicable	RHD01_348_2	proteomic profiling by mass spectrometry	RHD01_348_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_348_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-261	Homo sapiens	blood plasma	261	not applicable	not available	33	Male	not available	Rheumatic Heart Disease	depleted	261	not applicable	RHD01_349_1	proteomic profiling by mass spectrometry	RHD01_349_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_349_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-261	Homo sapiens	blood plasma	261	not applicable	not available	33	Male	not available	Rheumatic Heart Disease	depleted	261	not applicable	RHD01_349_2	proteomic profiling by mass spectrometry	RHD01_349_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_349_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-262	Homo sapiens	blood plasma	262	not applicable	not available	29	Female	not available	Normal	depleted	262	not applicable	RHD01_34_1	proteomic profiling by mass spectrometry	RHD01_34_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_34_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-262	Homo sapiens	blood plasma	262	not applicable	not available	29	Female	not available	Normal	depleted	262	not applicable	RHD01_34_2	proteomic profiling by mass spectrometry	RHD01_34_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_34_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-263	Homo sapiens	blood plasma	263	not applicable	not available	25	Male	not available	Normal	depleted	263	not applicable	RHD01_350_1	proteomic profiling by mass spectrometry	RHD01_350_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_350_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-263	Homo sapiens	blood plasma	263	not applicable	not available	25	Male	not available	Normal	depleted	263	not applicable	RHD01_350_2	proteomic profiling by mass spectrometry	RHD01_350_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_350_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-264	Homo sapiens	blood plasma	264	not applicable	not available	26	Male	not available	Normal	depleted	264	not applicable	RHD01_353_1	proteomic profiling by mass spectrometry	RHD01_353_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_353_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-264	Homo sapiens	blood plasma	264	not applicable	not available	26	Male	not available	Normal	depleted	264	not applicable	RHD01_353_2	proteomic profiling by mass spectrometry	RHD01_353_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_353_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-265	Homo sapiens	blood plasma	265	not applicable	not available	30	Male	not available	Normal	depleted	265	not applicable	RHD01_354_1	proteomic profiling by mass spectrometry	RHD01_354_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_354_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-265	Homo sapiens	blood plasma	265	not applicable	not available	30	Male	not available	Normal	depleted	265	not applicable	RHD01_354_2	proteomic profiling by mass spectrometry	RHD01_354_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_354_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-266	Homo sapiens	blood plasma	266	not applicable	not available	22	Male	not available	Normal	depleted	266	not applicable	RHD01_355_1	proteomic profiling by mass spectrometry	RHD01_355_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_355_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-266	Homo sapiens	blood plasma	266	not applicable	not available	22	Male	not available	Normal	depleted	266	not applicable	RHD01_355_2	proteomic profiling by mass spectrometry	RHD01_355_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_355_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-267	Homo sapiens	blood plasma	267	not applicable	not available	46	Male	not available	Normal	depleted	267	not applicable	RHD01_356_1	proteomic profiling by mass spectrometry	RHD01_356_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_356_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-267	Homo sapiens	blood plasma	267	not applicable	not available	46	Male	not available	Normal	depleted	267	not applicable	RHD01_356_2	proteomic profiling by mass spectrometry	RHD01_356_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_356_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-268	Homo sapiens	blood plasma	268	not applicable	not available	47	Female	not available	Normal	depleted	268	not applicable	RHD01_357_2	proteomic profiling by mass spectrometry	RHD01_357_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_357_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-268	Homo sapiens	blood plasma	268	not applicable	not available	47	Female	not available	Normal	depleted	268	not applicable	RHD01_357_2a	proteomic profiling by mass spectrometry	RHD01_357_2a.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_357_2a.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-269	Homo sapiens	blood plasma	269	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	269	not applicable	RHD01_358PR_1	proteomic profiling by mass spectrometry	RHD01_358PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_358PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-269	Homo sapiens	blood plasma	269	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	269	not applicable	RHD01_358PR_2	proteomic profiling by mass spectrometry	RHD01_358PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_358PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-270	Homo sapiens	blood plasma	270	not applicable	not available	27	Male	not available	Normal	depleted	270	not applicable	RHD01_359_1	proteomic profiling by mass spectrometry	RHD01_359_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_359_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-270	Homo sapiens	blood plasma	270	not applicable	not available	27	Male	not available	Normal	depleted	270	not applicable	RHD01_359_2	proteomic profiling by mass spectrometry	RHD01_359_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_359_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-271	Homo sapiens	blood plasma	271	not applicable	not available	18	Female	not available	Rheumatic Heart Disease	depleted	271	not applicable	RHD01_35_1	proteomic profiling by mass spectrometry	RHD01_35_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_35_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-271	Homo sapiens	blood plasma	271	not applicable	not available	18	Female	not available	Rheumatic Heart Disease	depleted	271	not applicable	RHD01_35_2	proteomic profiling by mass spectrometry	RHD01_35_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_35_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-272	Homo sapiens	blood plasma	272	not applicable	not available	17	Female	not available	Normal	depleted	272	not applicable	RHD01_360_1	proteomic profiling by mass spectrometry	RHD01_360_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_360_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-272	Homo sapiens	blood plasma	272	not applicable	not available	17	Female	not available	Normal	depleted	272	not applicable	RHD01_360_2	proteomic profiling by mass spectrometry	RHD01_360_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_360_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-273	Homo sapiens	blood plasma	273	not applicable	not available	21	Female	not available	Rheumatic Heart Disease	depleted	273	not applicable	RHD01_361_1	proteomic profiling by mass spectrometry	RHD01_361_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_361_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-273	Homo sapiens	blood plasma	273	not applicable	not available	21	Female	not available	Rheumatic Heart Disease	depleted	273	not applicable	RHD01_361_2	proteomic profiling by mass spectrometry	RHD01_361_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_361_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-274	Homo sapiens	blood plasma	274	not applicable	not available	31	Female	not available	Normal	depleted	274	not applicable	RHD01_362_1	proteomic profiling by mass spectrometry	RHD01_362_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_362_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-274	Homo sapiens	blood plasma	274	not applicable	not available	31	Female	not available	Normal	depleted	274	not applicable	RHD01_362_2	proteomic profiling by mass spectrometry	RHD01_362_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_362_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-275	Homo sapiens	blood plasma	275	not applicable	not available	14	Female	not available	Rheumatic Heart Disease	depleted	275	not applicable	RHD01_363PR_1	proteomic profiling by mass spectrometry	RHD01_363PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_363PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-275	Homo sapiens	blood plasma	275	not applicable	not available	14	Female	not available	Rheumatic Heart Disease	depleted	275	not applicable	RHD01_363PR_2	proteomic profiling by mass spectrometry	RHD01_363PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_363PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-276	Homo sapiens	blood plasma	276	not applicable	not available	18	Male	not available	Normal	depleted	276	not applicable	RHD01_364_1	proteomic profiling by mass spectrometry	RHD01_364_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_364_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-276	Homo sapiens	blood plasma	276	not applicable	not available	18	Male	not available	Normal	depleted	276	not applicable	RHD01_364_2	proteomic profiling by mass spectrometry	RHD01_364_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_364_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-277	Homo sapiens	blood plasma	277	not applicable	not available	26	Male	not available	Rheumatic Heart Disease	depleted	277	not applicable	RHD01_365_1	proteomic profiling by mass spectrometry	RHD01_365_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_365_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-277	Homo sapiens	blood plasma	277	not applicable	not available	26	Male	not available	Rheumatic Heart Disease	depleted	277	not applicable	RHD01_365_2	proteomic profiling by mass spectrometry	RHD01_365_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_365_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-278	Homo sapiens	blood plasma	278	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	278	not applicable	RHD01_366_1	proteomic profiling by mass spectrometry	RHD01_366_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_366_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-278	Homo sapiens	blood plasma	278	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	278	not applicable	RHD01_366_2	proteomic profiling by mass spectrometry	RHD01_366_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_366_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-279	Homo sapiens	blood plasma	279	not applicable	not available	25	Male	not available	Rheumatic Heart Disease	depleted	279	not applicable	RHD01_367_1	proteomic profiling by mass spectrometry	RHD01_367_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_367_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-279	Homo sapiens	blood plasma	279	not applicable	not available	25	Male	not available	Rheumatic Heart Disease	depleted	279	not applicable	RHD01_367_2	proteomic profiling by mass spectrometry	RHD01_367_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_367_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-280	Homo sapiens	blood plasma	280	not applicable	not available	54	Female	not available	Rheumatic Heart Disease	depleted	280	not applicable	RHD01_368_1	proteomic profiling by mass spectrometry	RHD01_368_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_368_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-280	Homo sapiens	blood plasma	280	not applicable	not available	54	Female	not available	Rheumatic Heart Disease	depleted	280	not applicable	RHD01_368_2	proteomic profiling by mass spectrometry	RHD01_368_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_368_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-281	Homo sapiens	blood plasma	281	not applicable	not available	40	Female	not available	Normal	depleted	281	not applicable	RHD01_369_1	proteomic profiling by mass spectrometry	RHD01_369_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_369_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-281	Homo sapiens	blood plasma	281	not applicable	not available	40	Female	not available	Normal	depleted	281	not applicable	RHD01_369_2	proteomic profiling by mass spectrometry	RHD01_369_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_369_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-282	Homo sapiens	blood plasma	282	not applicable	not available	29	Female	not available	Normal	depleted	282	not applicable	RHD01_36_1	proteomic profiling by mass spectrometry	RHD01_36_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_36_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-282	Homo sapiens	blood plasma	282	not applicable	not available	29	Female	not available	Normal	depleted	282	not applicable	RHD01_36_2	proteomic profiling by mass spectrometry	RHD01_36_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_36_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-283	Homo sapiens	blood plasma	283	not applicable	not available	44	Female	not available	Normal	depleted	283	not applicable	RHD01_370_1	proteomic profiling by mass spectrometry	RHD01_370_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_370_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-283	Homo sapiens	blood plasma	283	not applicable	not available	44	Female	not available	Normal	depleted	283	not applicable	RHD01_370_2	proteomic profiling by mass spectrometry	RHD01_370_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_370_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-284	Homo sapiens	blood plasma	284	not applicable	not available	11	Male	not available	Rheumatic Heart Disease	depleted	284	not applicable	RHD01_371_1	proteomic profiling by mass spectrometry	RHD01_371_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_371_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-284	Homo sapiens	blood plasma	284	not applicable	not available	11	Male	not available	Rheumatic Heart Disease	depleted	284	not applicable	RHD01_371_2	proteomic profiling by mass spectrometry	RHD01_371_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_371_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-285	Homo sapiens	blood plasma	285	not applicable	not available	49	Female	not available	Rheumatic Heart Disease	depleted	285	not applicable	RHD01_372_1	proteomic profiling by mass spectrometry	RHD01_372_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_372_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-285	Homo sapiens	blood plasma	285	not applicable	not available	49	Female	not available	Rheumatic Heart Disease	depleted	285	not applicable	RHD01_372_2	proteomic profiling by mass spectrometry	RHD01_372_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_372_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-286	Homo sapiens	blood plasma	286	not applicable	not available	18	Male	not available	Normal	depleted	286	not applicable	RHD01_373_1	proteomic profiling by mass spectrometry	RHD01_373_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_373_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-286	Homo sapiens	blood plasma	286	not applicable	not available	18	Male	not available	Normal	depleted	286	not applicable	RHD01_373_2	proteomic profiling by mass spectrometry	RHD01_373_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_373_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-287	Homo sapiens	blood plasma	287	not applicable	not available	16	Female	not available	Normal	depleted	287	not applicable	RHD01_374_1	proteomic profiling by mass spectrometry	RHD01_374_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_374_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-287	Homo sapiens	blood plasma	287	not applicable	not available	16	Female	not available	Normal	depleted	287	not applicable	RHD01_374_2	proteomic profiling by mass spectrometry	RHD01_374_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_374_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-288	Homo sapiens	blood plasma	288	not applicable	not available	22	Female	not available	Normal	depleted	288	not applicable	RHD01_375_1	proteomic profiling by mass spectrometry	RHD01_375_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_375_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-288	Homo sapiens	blood plasma	288	not applicable	not available	22	Female	not available	Normal	depleted	288	not applicable	RHD01_375_2	proteomic profiling by mass spectrometry	RHD01_375_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_375_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-289	Homo sapiens	blood plasma	289	not applicable	not available	42	Female	not available	Normal	depleted	289	not applicable	RHD01_376_1	proteomic profiling by mass spectrometry	RHD01_376_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_376_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-289	Homo sapiens	blood plasma	289	not applicable	not available	42	Female	not available	Normal	depleted	289	not applicable	RHD01_376_2	proteomic profiling by mass spectrometry	RHD01_376_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_376_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-290	Homo sapiens	blood plasma	290	not applicable	not available	11	Male	not available	Rheumatic Heart Disease	depleted	290	not applicable	RHD01_377_1	proteomic profiling by mass spectrometry	RHD01_377_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_377_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-290	Homo sapiens	blood plasma	290	not applicable	not available	11	Male	not available	Rheumatic Heart Disease	depleted	290	not applicable	RHD01_377_2	proteomic profiling by mass spectrometry	RHD01_377_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_377_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-291	Homo sapiens	blood plasma	291	not applicable	not available	9	Female	not available	Rheumatic Heart Disease	depleted	291	not applicable	RHD01_378_1	proteomic profiling by mass spectrometry	RHD01_378_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_378_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-291	Homo sapiens	blood plasma	291	not applicable	not available	9	Female	not available	Rheumatic Heart Disease	depleted	291	not applicable	RHD01_378_2	proteomic profiling by mass spectrometry	RHD01_378_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_378_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-292	Homo sapiens	blood plasma	292	not applicable	not available	17	Female	not available	Rheumatic Heart Disease	depleted	292	not applicable	RHD01_379_1	proteomic profiling by mass spectrometry	RHD01_379_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_379_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-292	Homo sapiens	blood plasma	292	not applicable	not available	17	Female	not available	Rheumatic Heart Disease	depleted	292	not applicable	RHD01_379_2	proteomic profiling by mass spectrometry	RHD01_379_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_379_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-293	Homo sapiens	blood plasma	293	not applicable	not available	50	Female	not available	Normal	depleted	293	not applicable	RHD01_37_1	proteomic profiling by mass spectrometry	RHD01_37_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_37_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-293	Homo sapiens	blood plasma	293	not applicable	not available	50	Female	not available	Normal	depleted	293	not applicable	RHD01_37_2	proteomic profiling by mass spectrometry	RHD01_37_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_37_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-294	Homo sapiens	blood plasma	294	not applicable	not available	25	Female	not available	Rheumatic Heart Disease	depleted	294	not applicable	RHD01_380_1	proteomic profiling by mass spectrometry	RHD01_380_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_380_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-294	Homo sapiens	blood plasma	294	not applicable	not available	25	Female	not available	Rheumatic Heart Disease	depleted	294	not applicable	RHD01_380_2	proteomic profiling by mass spectrometry	RHD01_380_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_380_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-295	Homo sapiens	blood plasma	295	not applicable	not available	7	Female	not available	Rheumatic Heart Disease	depleted	295	not applicable	RHD01_381_1	proteomic profiling by mass spectrometry	RHD01_381_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_381_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-295	Homo sapiens	blood plasma	295	not applicable	not available	7	Female	not available	Rheumatic Heart Disease	depleted	295	not applicable	RHD01_381_2	proteomic profiling by mass spectrometry	RHD01_381_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_381_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-296	Homo sapiens	blood plasma	296	not applicable	not available	21	Female	not available	Normal	depleted	296	not applicable	RHD01_382PR_1	proteomic profiling by mass spectrometry	RHD01_382PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_382PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-296	Homo sapiens	blood plasma	296	not applicable	not available	21	Female	not available	Normal	depleted	296	not applicable	RHD01_382PR_2	proteomic profiling by mass spectrometry	RHD01_382PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_382PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-297	Homo sapiens	blood plasma	297	not applicable	not available	44	Female	not available	Normal	depleted	297	not applicable	RHD01_383_1	proteomic profiling by mass spectrometry	RHD01_383_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_383_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-297	Homo sapiens	blood plasma	297	not applicable	not available	44	Female	not available	Normal	depleted	297	not applicable	RHD01_383_2	proteomic profiling by mass spectrometry	RHD01_383_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_383_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-298	Homo sapiens	blood plasma	298	not applicable	not available	23	Male	not available	Rheumatic Heart Disease	depleted	298	not applicable	RHD01_384_1	proteomic profiling by mass spectrometry	RHD01_384_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_384_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-298	Homo sapiens	blood plasma	298	not applicable	not available	23	Male	not available	Rheumatic Heart Disease	depleted	298	not applicable	RHD01_384_2	proteomic profiling by mass spectrometry	RHD01_384_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_384_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-299	Homo sapiens	blood plasma	299	not applicable	not available	44	Female	not available	Normal	depleted	299	not applicable	RHD01_385_1	proteomic profiling by mass spectrometry	RHD01_385_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_385_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-299	Homo sapiens	blood plasma	299	not applicable	not available	44	Female	not available	Normal	depleted	299	not applicable	RHD01_385_2	proteomic profiling by mass spectrometry	RHD01_385_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_385_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-300	Homo sapiens	blood plasma	300	not applicable	not available	28	Male	not available	Normal	depleted	300	not applicable	RHD01_386_1	proteomic profiling by mass spectrometry	RHD01_386_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_386_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-300	Homo sapiens	blood plasma	300	not applicable	not available	28	Male	not available	Normal	depleted	300	not applicable	RHD01_386_2	proteomic profiling by mass spectrometry	RHD01_386_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_386_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-301	Homo sapiens	blood plasma	301	not applicable	not available	51	Female	not available	Rheumatic Heart Disease	depleted	301	not applicable	RHD01_387_1	proteomic profiling by mass spectrometry	RHD01_387_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_387_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-301	Homo sapiens	blood plasma	301	not applicable	not available	51	Female	not available	Rheumatic Heart Disease	depleted	301	not applicable	RHD01_387_2	proteomic profiling by mass spectrometry	RHD01_387_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_387_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-302	Homo sapiens	blood plasma	302	not applicable	not available	36	Female	not available	Normal	depleted	302	not applicable	RHD01_388_1	proteomic profiling by mass spectrometry	RHD01_388_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_388_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-302	Homo sapiens	blood plasma	302	not applicable	not available	36	Female	not available	Normal	depleted	302	not applicable	RHD01_388_2	proteomic profiling by mass spectrometry	RHD01_388_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_388_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-303	Homo sapiens	blood plasma	303	not applicable	not available	42	Female	not available	Normal	depleted	303	not applicable	RHD01_389_1	proteomic profiling by mass spectrometry	RHD01_389_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_389_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-303	Homo sapiens	blood plasma	303	not applicable	not available	42	Female	not available	Normal	depleted	303	not applicable	RHD01_389_2	proteomic profiling by mass spectrometry	RHD01_389_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_389_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-304	Homo sapiens	blood plasma	304	not applicable	not available	43	Male	not available	Normal	depleted	304	not applicable	RHD01_38_1	proteomic profiling by mass spectrometry	RHD01_38_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_38_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-304	Homo sapiens	blood plasma	304	not applicable	not available	43	Male	not available	Normal	depleted	304	not applicable	RHD01_38_2	proteomic profiling by mass spectrometry	RHD01_38_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_38_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-305	Homo sapiens	blood plasma	305	not applicable	not available	15	Female	not available	Rheumatic Heart Disease	depleted	305	not applicable	RHD01_390_1	proteomic profiling by mass spectrometry	RHD01_390_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_390_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-305	Homo sapiens	blood plasma	305	not applicable	not available	15	Female	not available	Rheumatic Heart Disease	depleted	305	not applicable	RHD01_390_2	proteomic profiling by mass spectrometry	RHD01_390_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_390_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-306	Homo sapiens	blood plasma	306	not applicable	not available	30	Female	not available	Normal	depleted	306	not applicable	RHD01_391_1	proteomic profiling by mass spectrometry	RHD01_391_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_391_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-306	Homo sapiens	blood plasma	306	not applicable	not available	30	Female	not available	Normal	depleted	306	not applicable	RHD01_391_2	proteomic profiling by mass spectrometry	RHD01_391_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_391_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-307	Homo sapiens	blood plasma	307	not applicable	not available	28	Female	not available	Normal	depleted	307	not applicable	RHD01_393_1	proteomic profiling by mass spectrometry	RHD01_393_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_393_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-307	Homo sapiens	blood plasma	307	not applicable	not available	28	Female	not available	Normal	depleted	307	not applicable	RHD01_393_2	proteomic profiling by mass spectrometry	RHD01_393_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_393_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-308	Homo sapiens	blood plasma	308	not applicable	not available	31	Female	not available	Normal	depleted	308	not applicable	RHD01_394_1	proteomic profiling by mass spectrometry	RHD01_394_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_394_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-308	Homo sapiens	blood plasma	308	not applicable	not available	31	Female	not available	Normal	depleted	308	not applicable	RHD01_394_2	proteomic profiling by mass spectrometry	RHD01_394_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_394_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-309	Homo sapiens	blood plasma	309	not applicable	not available	23	Female	not available	Normal	depleted	309	not applicable	RHD01_395_1	proteomic profiling by mass spectrometry	RHD01_395_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_395_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-309	Homo sapiens	blood plasma	309	not applicable	not available	23	Female	not available	Normal	depleted	309	not applicable	RHD01_395_2	proteomic profiling by mass spectrometry	RHD01_395_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_395_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-310	Homo sapiens	blood plasma	310	not applicable	not available	26	Female	not available	Rheumatic Heart Disease	depleted	310	not applicable	RHD01_396_1	proteomic profiling by mass spectrometry	RHD01_396_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_396_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-310	Homo sapiens	blood plasma	310	not applicable	not available	26	Female	not available	Rheumatic Heart Disease	depleted	310	not applicable	RHD01_396_2	proteomic profiling by mass spectrometry	RHD01_396_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_396_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-311	Homo sapiens	blood plasma	311	not applicable	not available	46	Female	not available	Rheumatic Heart Disease	depleted	311	not applicable	RHD01_397_1	proteomic profiling by mass spectrometry	RHD01_397_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_397_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-311	Homo sapiens	blood plasma	311	not applicable	not available	46	Female	not available	Rheumatic Heart Disease	depleted	311	not applicable	RHD01_397_2	proteomic profiling by mass spectrometry	RHD01_397_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_397_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-312	Homo sapiens	blood plasma	312	not applicable	not available	23	Female	not available	Normal	depleted	312	not applicable	RHD01_398_1	proteomic profiling by mass spectrometry	RHD01_398_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_398_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-312	Homo sapiens	blood plasma	312	not applicable	not available	23	Female	not available	Normal	depleted	312	not applicable	RHD01_398_2	proteomic profiling by mass spectrometry	RHD01_398_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_398_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-313	Homo sapiens	blood plasma	313	not applicable	not available	36	Male	not available	Rheumatic Heart Disease	depleted	313	not applicable	RHD01_399_1	proteomic profiling by mass spectrometry	RHD01_399_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_399_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-313	Homo sapiens	blood plasma	313	not applicable	not available	36	Male	not available	Rheumatic Heart Disease	depleted	313	not applicable	RHD01_399_2	proteomic profiling by mass spectrometry	RHD01_399_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_399_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-314	Homo sapiens	blood plasma	314	not applicable	not available	23	Female	not available	Normal	depleted	314	not applicable	RHD01_39_1	proteomic profiling by mass spectrometry	RHD01_39_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_39_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-314	Homo sapiens	blood plasma	314	not applicable	not available	23	Female	not available	Normal	depleted	314	not applicable	RHD01_39_2	proteomic profiling by mass spectrometry	RHD01_39_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_39_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-315	Homo sapiens	blood plasma	315	not applicable	not available	21	Female	not available	Rheumatic Heart Disease	depleted	315	not applicable	RHD01_3_1	proteomic profiling by mass spectrometry	RHD01_3_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_3_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-315	Homo sapiens	blood plasma	315	not applicable	not available	21	Female	not available	Rheumatic Heart Disease	depleted	315	not applicable	RHD01_3_2	proteomic profiling by mass spectrometry	RHD01_3_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_3_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-316	Homo sapiens	blood plasma	316	not applicable	not available	17	Male	not available	Rheumatic Heart Disease	depleted	316	not applicable	RHD01_400_1	proteomic profiling by mass spectrometry	RHD01_400_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_400_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-316	Homo sapiens	blood plasma	316	not applicable	not available	17	Male	not available	Rheumatic Heart Disease	depleted	316	not applicable	RHD01_400_2	proteomic profiling by mass spectrometry	RHD01_400_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_400_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-317	Homo sapiens	blood plasma	317	not applicable	not available	47	Female	not available	Rheumatic Heart Disease	depleted	317	not applicable	RHD01_401_1	proteomic profiling by mass spectrometry	RHD01_401_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_401_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-317	Homo sapiens	blood plasma	317	not applicable	not available	47	Female	not available	Rheumatic Heart Disease	depleted	317	not applicable	RHD01_401_2	proteomic profiling by mass spectrometry	RHD01_401_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_401_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-318	Homo sapiens	blood plasma	318	not applicable	not available	24	Female	not available	Normal	depleted	318	not applicable	RHD01_402_1	proteomic profiling by mass spectrometry	RHD01_402_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_402_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-318	Homo sapiens	blood plasma	318	not applicable	not available	24	Female	not available	Normal	depleted	318	not applicable	RHD01_402_2	proteomic profiling by mass spectrometry	RHD01_402_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_402_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-319	Homo sapiens	blood plasma	319	not applicable	not available	24	Female	not available	Normal	depleted	319	not applicable	RHD01_403_1	proteomic profiling by mass spectrometry	RHD01_403_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_403_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-319	Homo sapiens	blood plasma	319	not applicable	not available	24	Female	not available	Normal	depleted	319	not applicable	RHD01_403_2	proteomic profiling by mass spectrometry	RHD01_403_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_403_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-320	Homo sapiens	blood plasma	320	not applicable	not available	39	Female	not available	Normal	depleted	320	not applicable	RHD01_404_1	proteomic profiling by mass spectrometry	RHD01_404_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_404_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-320	Homo sapiens	blood plasma	320	not applicable	not available	39	Female	not available	Normal	depleted	320	not applicable	RHD01_404_2	proteomic profiling by mass spectrometry	RHD01_404_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_404_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-321	Homo sapiens	blood plasma	321	not applicable	not available	23	Female	not available	Normal	depleted	321	not applicable	RHD01_405_1	proteomic profiling by mass spectrometry	RHD01_405_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_405_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-321	Homo sapiens	blood plasma	321	not applicable	not available	23	Female	not available	Normal	depleted	321	not applicable	RHD01_405_2	proteomic profiling by mass spectrometry	RHD01_405_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_405_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-322	Homo sapiens	blood plasma	322	not applicable	not available	42	Female	not available	Rheumatic Heart Disease	depleted	322	not applicable	RHD01_406_1	proteomic profiling by mass spectrometry	RHD01_406_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_406_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-322	Homo sapiens	blood plasma	322	not applicable	not available	42	Female	not available	Rheumatic Heart Disease	depleted	322	not applicable	RHD01_406_2	proteomic profiling by mass spectrometry	RHD01_406_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_406_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-323	Homo sapiens	blood plasma	323	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	323	not applicable	RHD01_407_1	proteomic profiling by mass spectrometry	RHD01_407_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_407_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-323	Homo sapiens	blood plasma	323	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	323	not applicable	RHD01_407_2	proteomic profiling by mass spectrometry	RHD01_407_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_407_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-324	Homo sapiens	blood plasma	324	not applicable	not available	19	Female	not available	Normal	depleted	324	not applicable	RHD01_408_1	proteomic profiling by mass spectrometry	RHD01_408_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_408_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-324	Homo sapiens	blood plasma	324	not applicable	not available	19	Female	not available	Normal	depleted	324	not applicable	RHD01_408_2	proteomic profiling by mass spectrometry	RHD01_408_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_408_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-325	Homo sapiens	blood plasma	325	not applicable	not available	37	Female	not available	Rheumatic Heart Disease	depleted	325	not applicable	RHD01_409_1	proteomic profiling by mass spectrometry	RHD01_409_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_409_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-325	Homo sapiens	blood plasma	325	not applicable	not available	37	Female	not available	Rheumatic Heart Disease	depleted	325	not applicable	RHD01_409_2	proteomic profiling by mass spectrometry	RHD01_409_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_409_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-326	Homo sapiens	blood plasma	326	not applicable	not available	22	Female	not available	Normal	depleted	326	not applicable	RHD01_40_1	proteomic profiling by mass spectrometry	RHD01_40_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_40_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-326	Homo sapiens	blood plasma	326	not applicable	not available	22	Female	not available	Normal	depleted	326	not applicable	RHD01_40_2	proteomic profiling by mass spectrometry	RHD01_40_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_40_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-327	Homo sapiens	blood plasma	327	not applicable	not available	57	Female	not available	Rheumatic Heart Disease	depleted	327	not applicable	RHD01_410_1	proteomic profiling by mass spectrometry	RHD01_410_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_410_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-327	Homo sapiens	blood plasma	327	not applicable	not available	57	Female	not available	Rheumatic Heart Disease	depleted	327	not applicable	RHD01_410_2	proteomic profiling by mass spectrometry	RHD01_410_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_410_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-328	Homo sapiens	blood plasma	328	not applicable	not available	17	Male	not available	Normal	depleted	328	not applicable	RHD01_411_1	proteomic profiling by mass spectrometry	RHD01_411_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_411_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-328	Homo sapiens	blood plasma	328	not applicable	not available	17	Male	not available	Normal	depleted	328	not applicable	RHD01_411_2	proteomic profiling by mass spectrometry	RHD01_411_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_411_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-329	Homo sapiens	blood plasma	329	not applicable	not available	61	Female	not available	Rheumatic Heart Disease	depleted	329	not applicable	RHD01_412_1	proteomic profiling by mass spectrometry	RHD01_412_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_412_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-329	Homo sapiens	blood plasma	329	not applicable	not available	61	Female	not available	Rheumatic Heart Disease	depleted	329	not applicable	RHD01_412_2	proteomic profiling by mass spectrometry	RHD01_412_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_412_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-330	Homo sapiens	blood plasma	330	not applicable	not available	41	Female	not available	Normal	depleted	330	not applicable	RHD01_413_1	proteomic profiling by mass spectrometry	RHD01_413_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_413_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-330	Homo sapiens	blood plasma	330	not applicable	not available	41	Female	not available	Normal	depleted	330	not applicable	RHD01_413_2	proteomic profiling by mass spectrometry	RHD01_413_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_413_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-331	Homo sapiens	blood plasma	331	not applicable	not available	21	Female	not available	Normal	depleted	331	not applicable	RHD01_414_1	proteomic profiling by mass spectrometry	RHD01_414_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_414_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-331	Homo sapiens	blood plasma	331	not applicable	not available	21	Female	not available	Normal	depleted	331	not applicable	RHD01_414_2	proteomic profiling by mass spectrometry	RHD01_414_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_414_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-332	Homo sapiens	blood plasma	332	not applicable	not available	36	Male	not available	Normal	depleted	332	not applicable	RHD01_415_1	proteomic profiling by mass spectrometry	RHD01_415_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_415_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-332	Homo sapiens	blood plasma	332	not applicable	not available	36	Male	not available	Normal	depleted	332	not applicable	RHD01_415_2	proteomic profiling by mass spectrometry	RHD01_415_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_415_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-333	Homo sapiens	blood plasma	333	not applicable	not available	21	Female	not available	Normal	depleted	333	not applicable	RHD01_416PR_1	proteomic profiling by mass spectrometry	RHD01_416PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_416PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-333	Homo sapiens	blood plasma	333	not applicable	not available	21	Female	not available	Normal	depleted	333	not applicable	RHD01_416PR_2	proteomic profiling by mass spectrometry	RHD01_416PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_416PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-334	Homo sapiens	blood plasma	334	not applicable	not available	47	Female	not available	Rheumatic Heart Disease	depleted	334	not applicable	RHD01_417_1	proteomic profiling by mass spectrometry	RHD01_417_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_417_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-334	Homo sapiens	blood plasma	334	not applicable	not available	47	Female	not available	Rheumatic Heart Disease	depleted	334	not applicable	RHD01_417_2	proteomic profiling by mass spectrometry	RHD01_417_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_417_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-335	Homo sapiens	blood plasma	335	not applicable	not available	7	Male	not available	Rheumatic Heart Disease	depleted	335	not applicable	RHD01_418_1	proteomic profiling by mass spectrometry	RHD01_418_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_418_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-335	Homo sapiens	blood plasma	335	not applicable	not available	7	Male	not available	Rheumatic Heart Disease	depleted	335	not applicable	RHD01_418_2	proteomic profiling by mass spectrometry	RHD01_418_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_418_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-336	Homo sapiens	blood plasma	336	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	336	not applicable	RHD01_419_1	proteomic profiling by mass spectrometry	RHD01_419_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_419_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-336	Homo sapiens	blood plasma	336	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	336	not applicable	RHD01_419_2	proteomic profiling by mass spectrometry	RHD01_419_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_419_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-337	Homo sapiens	blood plasma	337	not applicable	not available	34	Female	not available	Rheumatic Heart Disease	depleted	337	not applicable	RHD01_41_1	proteomic profiling by mass spectrometry	RHD01_41_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_41_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-337	Homo sapiens	blood plasma	337	not applicable	not available	34	Female	not available	Rheumatic Heart Disease	depleted	337	not applicable	RHD01_41_2	proteomic profiling by mass spectrometry	RHD01_41_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_41_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-338	Homo sapiens	blood plasma	338	not applicable	not available	45	Male	not available	Normal	depleted	338	not applicable	RHD01_420_1	proteomic profiling by mass spectrometry	RHD01_420_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_420_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-338	Homo sapiens	blood plasma	338	not applicable	not available	45	Male	not available	Normal	depleted	338	not applicable	RHD01_420_2	proteomic profiling by mass spectrometry	RHD01_420_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_420_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-339	Homo sapiens	blood plasma	339	not applicable	not available	37	Male	not available	Normal	depleted	339	not applicable	RHD01_421_1	proteomic profiling by mass spectrometry	RHD01_421_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_421_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-339	Homo sapiens	blood plasma	339	not applicable	not available	37	Male	not available	Normal	depleted	339	not applicable	RHD01_421_2	proteomic profiling by mass spectrometry	RHD01_421_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_421_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-340	Homo sapiens	blood plasma	340	not applicable	not available	6	Male	not available	Rheumatic Heart Disease	depleted	340	not applicable	RHD01_422_1	proteomic profiling by mass spectrometry	RHD01_422_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_422_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-340	Homo sapiens	blood plasma	340	not applicable	not available	6	Male	not available	Rheumatic Heart Disease	depleted	340	not applicable	RHD01_422_2	proteomic profiling by mass spectrometry	RHD01_422_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_422_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-341	Homo sapiens	blood plasma	341	not applicable	not available	16	Male	not available	Rheumatic Heart Disease	depleted	341	not applicable	RHD01_424_1	proteomic profiling by mass spectrometry	RHD01_424_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_424_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-341	Homo sapiens	blood plasma	341	not applicable	not available	16	Male	not available	Rheumatic Heart Disease	depleted	341	not applicable	RHD01_424_2	proteomic profiling by mass spectrometry	RHD01_424_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_424_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-342	Homo sapiens	blood plasma	342	not applicable	not available	18	Male	not available	Normal	depleted	342	not applicable	RHD01_425_1	proteomic profiling by mass spectrometry	RHD01_425_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_425_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-342	Homo sapiens	blood plasma	342	not applicable	not available	18	Male	not available	Normal	depleted	342	not applicable	RHD01_425_2	proteomic profiling by mass spectrometry	RHD01_425_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_425_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-343	Homo sapiens	blood plasma	343	not applicable	not available	6	Female	not available	Rheumatic Heart Disease	depleted	343	not applicable	RHD01_426_1	proteomic profiling by mass spectrometry	RHD01_426_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_426_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-343	Homo sapiens	blood plasma	343	not applicable	not available	6	Female	not available	Rheumatic Heart Disease	depleted	343	not applicable	RHD01_426_2	proteomic profiling by mass spectrometry	RHD01_426_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_426_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-344	Homo sapiens	blood plasma	344	not applicable	not available	56	Male	not available	Rheumatic Heart Disease	depleted	344	not applicable	RHD01_427_1	proteomic profiling by mass spectrometry	RHD01_427_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_427_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-344	Homo sapiens	blood plasma	344	not applicable	not available	56	Male	not available	Rheumatic Heart Disease	depleted	344	not applicable	RHD01_427_2	proteomic profiling by mass spectrometry	RHD01_427_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_427_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-345	Homo sapiens	blood plasma	345	not applicable	not available	45	Female	not available	Rheumatic Heart Disease	depleted	345	not applicable	RHD01_428_1	proteomic profiling by mass spectrometry	RHD01_428_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_428_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-345	Homo sapiens	blood plasma	345	not applicable	not available	45	Female	not available	Rheumatic Heart Disease	depleted	345	not applicable	RHD01_428_2	proteomic profiling by mass spectrometry	RHD01_428_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_428_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-346	Homo sapiens	blood plasma	346	not applicable	not available	29	Female	not available	Normal	depleted	346	not applicable	RHD01_429_1	proteomic profiling by mass spectrometry	RHD01_429_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_429_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-346	Homo sapiens	blood plasma	346	not applicable	not available	29	Female	not available	Normal	depleted	346	not applicable	RHD01_429_2	proteomic profiling by mass spectrometry	RHD01_429_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_429_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-347	Homo sapiens	blood plasma	347	not applicable	not available	29	Female	not available	Normal	depleted	347	not applicable	RHD01_42_1	proteomic profiling by mass spectrometry	RHD01_42_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_42_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-347	Homo sapiens	blood plasma	347	not applicable	not available	29	Female	not available	Normal	depleted	347	not applicable	RHD01_42_2	proteomic profiling by mass spectrometry	RHD01_42_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_42_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-348	Homo sapiens	blood plasma	348	not applicable	not available	8	Female	not available	Rheumatic Heart Disease	depleted	348	not applicable	RHD01_430_1	proteomic profiling by mass spectrometry	RHD01_430_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_430_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-348	Homo sapiens	blood plasma	348	not applicable	not available	8	Female	not available	Rheumatic Heart Disease	depleted	348	not applicable	RHD01_430_2	proteomic profiling by mass spectrometry	RHD01_430_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_430_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-349	Homo sapiens	blood plasma	349	not applicable	not available	26	Female	not available	Normal	depleted	349	not applicable	RHD01_431_1	proteomic profiling by mass spectrometry	RHD01_431_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_431_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-349	Homo sapiens	blood plasma	349	not applicable	not available	26	Female	not available	Normal	depleted	349	not applicable	RHD01_431_2	proteomic profiling by mass spectrometry	RHD01_431_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_431_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-350	Homo sapiens	blood plasma	350	not applicable	not available	52	Female	not available	Rheumatic Heart Disease	depleted	350	not applicable	RHD01_432_1	proteomic profiling by mass spectrometry	RHD01_432_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_432_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-350	Homo sapiens	blood plasma	350	not applicable	not available	52	Female	not available	Rheumatic Heart Disease	depleted	350	not applicable	RHD01_432_2	proteomic profiling by mass spectrometry	RHD01_432_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_432_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-351	Homo sapiens	blood plasma	351	not applicable	not available	15	Female	not available	Rheumatic Heart Disease	depleted	351	not applicable	RHD01_433_1	proteomic profiling by mass spectrometry	RHD01_433_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_433_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-351	Homo sapiens	blood plasma	351	not applicable	not available	15	Female	not available	Rheumatic Heart Disease	depleted	351	not applicable	RHD01_433_2	proteomic profiling by mass spectrometry	RHD01_433_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_433_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-352	Homo sapiens	blood plasma	352	not applicable	not available	35	Female	not available	Normal	depleted	352	not applicable	RHD01_434_1	proteomic profiling by mass spectrometry	RHD01_434_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_434_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-352	Homo sapiens	blood plasma	352	not applicable	not available	35	Female	not available	Normal	depleted	352	not applicable	RHD01_434_2	proteomic profiling by mass spectrometry	RHD01_434_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_434_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-353	Homo sapiens	blood plasma	353	not applicable	not available	28	Female	not available	Rheumatic Heart Disease	depleted	353	not applicable	RHD01_435_1	proteomic profiling by mass spectrometry	RHD01_435_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_435_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-353	Homo sapiens	blood plasma	353	not applicable	not available	28	Female	not available	Rheumatic Heart Disease	depleted	353	not applicable	RHD01_435_2	proteomic profiling by mass spectrometry	RHD01_435_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_435_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-354	Homo sapiens	blood plasma	354	not applicable	not available	52	Female	not available	Rheumatic Heart Disease	depleted	354	not applicable	RHD01_436_1	proteomic profiling by mass spectrometry	RHD01_436_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_436_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-354	Homo sapiens	blood plasma	354	not applicable	not available	52	Female	not available	Rheumatic Heart Disease	depleted	354	not applicable	RHD01_436_2	proteomic profiling by mass spectrometry	RHD01_436_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_436_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-355	Homo sapiens	blood plasma	355	not applicable	not available	30	Male	not available	Normal	depleted	355	not applicable	RHD01_437_1	proteomic profiling by mass spectrometry	RHD01_437_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_437_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-355	Homo sapiens	blood plasma	355	not applicable	not available	30	Male	not available	Normal	depleted	355	not applicable	RHD01_437_2	proteomic profiling by mass spectrometry	RHD01_437_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_437_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-356	Homo sapiens	blood plasma	356	not applicable	not available	27	Female	not available	Rheumatic Heart Disease	depleted	356	not applicable	RHD01_438_1	proteomic profiling by mass spectrometry	RHD01_438_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_438_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-356	Homo sapiens	blood plasma	356	not applicable	not available	27	Female	not available	Rheumatic Heart Disease	depleted	356	not applicable	RHD01_438_2	proteomic profiling by mass spectrometry	RHD01_438_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_438_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-357	Homo sapiens	blood plasma	357	not applicable	not available	49	Female	not available	Normal	depleted	357	not applicable	RHD01_439PR_1	proteomic profiling by mass spectrometry	RHD01_439PR_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_439PR_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-357	Homo sapiens	blood plasma	357	not applicable	not available	49	Female	not available	Normal	depleted	357	not applicable	RHD01_439PR_2	proteomic profiling by mass spectrometry	RHD01_439PR_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_439PR_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-358	Homo sapiens	blood plasma	358	not applicable	not available	36	Female	not available	Normal	depleted	358	not applicable	RHD01_43_1	proteomic profiling by mass spectrometry	RHD01_43_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_43_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-358	Homo sapiens	blood plasma	358	not applicable	not available	36	Female	not available	Normal	depleted	358	not applicable	RHD01_43_2	proteomic profiling by mass spectrometry	RHD01_43_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_43_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-359	Homo sapiens	blood plasma	359	not applicable	not available	27	Female	not available	Normal	depleted	359	not applicable	RHD01_440_1	proteomic profiling by mass spectrometry	RHD01_440_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_440_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-359	Homo sapiens	blood plasma	359	not applicable	not available	27	Female	not available	Normal	depleted	359	not applicable	RHD01_440_2	proteomic profiling by mass spectrometry	RHD01_440_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_440_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-360	Homo sapiens	blood plasma	360	not applicable	not available	31	Female	not available	Rheumatic Heart Disease	depleted	360	not applicable	RHD01_441_1	proteomic profiling by mass spectrometry	RHD01_441_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_441_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-360	Homo sapiens	blood plasma	360	not applicable	not available	31	Female	not available	Rheumatic Heart Disease	depleted	360	not applicable	RHD01_441_2	proteomic profiling by mass spectrometry	RHD01_441_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_441_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-361	Homo sapiens	blood plasma	361	not applicable	not available	59	Female	not available	Rheumatic Heart Disease	depleted	361	not applicable	RHD01_442_1	proteomic profiling by mass spectrometry	RHD01_442_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_442_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-361	Homo sapiens	blood plasma	361	not applicable	not available	59	Female	not available	Rheumatic Heart Disease	depleted	361	not applicable	RHD01_442_2	proteomic profiling by mass spectrometry	RHD01_442_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_442_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-362	Homo sapiens	blood plasma	362	not applicable	not available	25	Female	not available	Normal	depleted	362	not applicable	RHD01_443_1	proteomic profiling by mass spectrometry	RHD01_443_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_443_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-362	Homo sapiens	blood plasma	362	not applicable	not available	25	Female	not available	Normal	depleted	362	not applicable	RHD01_443_2	proteomic profiling by mass spectrometry	RHD01_443_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_443_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-363	Homo sapiens	blood plasma	363	not applicable	not available	21	Female	not available	Normal	depleted	363	not applicable	RHD01_444_1	proteomic profiling by mass spectrometry	RHD01_444_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_444_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-363	Homo sapiens	blood plasma	363	not applicable	not available	21	Female	not available	Normal	depleted	363	not applicable	RHD01_444_2	proteomic profiling by mass spectrometry	RHD01_444_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_444_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-364	Homo sapiens	blood plasma	364	not applicable	not available	15	Female	not available	Rheumatic Heart Disease	depleted	364	not applicable	RHD01_445_1	proteomic profiling by mass spectrometry	RHD01_445_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_445_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-364	Homo sapiens	blood plasma	364	not applicable	not available	15	Female	not available	Rheumatic Heart Disease	depleted	364	not applicable	RHD01_445_2	proteomic profiling by mass spectrometry	RHD01_445_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_445_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-365	Homo sapiens	blood plasma	365	not applicable	not available	12	Female	not available	Rheumatic Heart Disease	depleted	365	not applicable	RHD01_446_1	proteomic profiling by mass spectrometry	RHD01_446_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_446_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-365	Homo sapiens	blood plasma	365	not applicable	not available	12	Female	not available	Rheumatic Heart Disease	depleted	365	not applicable	RHD01_446_2	proteomic profiling by mass spectrometry	RHD01_446_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_446_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-366	Homo sapiens	blood plasma	366	not applicable	not available	39	Female	not available	Normal	depleted	366	not applicable	RHD01_447_1	proteomic profiling by mass spectrometry	RHD01_447_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_447_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-366	Homo sapiens	blood plasma	366	not applicable	not available	39	Female	not available	Normal	depleted	366	not applicable	RHD01_447_2	proteomic profiling by mass spectrometry	RHD01_447_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_447_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-367	Homo sapiens	blood plasma	367	not applicable	not available	34	Female	not available	Rheumatic Heart Disease	depleted	367	not applicable	RHD01_448_1	proteomic profiling by mass spectrometry	RHD01_448_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_448_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-367	Homo sapiens	blood plasma	367	not applicable	not available	34	Female	not available	Rheumatic Heart Disease	depleted	367	not applicable	RHD01_448_2	proteomic profiling by mass spectrometry	RHD01_448_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_448_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-368	Homo sapiens	blood plasma	368	not applicable	not available	27	Male	not available	Normal	depleted	368	not applicable	RHD01_449_1	proteomic profiling by mass spectrometry	RHD01_449_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_449_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-368	Homo sapiens	blood plasma	368	not applicable	not available	27	Male	not available	Normal	depleted	368	not applicable	RHD01_449_2	proteomic profiling by mass spectrometry	RHD01_449_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_449_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-369	Homo sapiens	blood plasma	369	not applicable	not available	32	Female	not available	Rheumatic Heart Disease	depleted	369	not applicable	RHD01_44_1	proteomic profiling by mass spectrometry	RHD01_44_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_44_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-369	Homo sapiens	blood plasma	369	not applicable	not available	32	Female	not available	Rheumatic Heart Disease	depleted	369	not applicable	RHD01_44_2	proteomic profiling by mass spectrometry	RHD01_44_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_44_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-370	Homo sapiens	blood plasma	370	not applicable	not available	44	Male	not available	Normal	depleted	370	not applicable	RHD01_450_1	proteomic profiling by mass spectrometry	RHD01_450_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_450_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-370	Homo sapiens	blood plasma	370	not applicable	not available	44	Male	not available	Normal	depleted	370	not applicable	RHD01_450_2	proteomic profiling by mass spectrometry	RHD01_450_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_450_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-371	Homo sapiens	blood plasma	371	not applicable	not available	6	Male	not available	Rheumatic Heart Disease	depleted	371	not applicable	RHD01_451_1	proteomic profiling by mass spectrometry	RHD01_451_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_451_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-371	Homo sapiens	blood plasma	371	not applicable	not available	6	Male	not available	Rheumatic Heart Disease	depleted	371	not applicable	RHD01_451_2	proteomic profiling by mass spectrometry	RHD01_451_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_451_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-372	Homo sapiens	blood plasma	372	not applicable	not available	22	Male	not available	Normal	depleted	372	not applicable	RHD01_452_1	proteomic profiling by mass spectrometry	RHD01_452_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_452_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-372	Homo sapiens	blood plasma	372	not applicable	not available	22	Male	not available	Normal	depleted	372	not applicable	RHD01_452_2	proteomic profiling by mass spectrometry	RHD01_452_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_452_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-373	Homo sapiens	blood plasma	373	not applicable	not available	26	Female	not available	Normal	depleted	373	not applicable	RHD01_453_1	proteomic profiling by mass spectrometry	RHD01_453_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_453_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-373	Homo sapiens	blood plasma	373	not applicable	not available	26	Female	not available	Normal	depleted	373	not applicable	RHD01_453_2	proteomic profiling by mass spectrometry	RHD01_453_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_453_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-374	Homo sapiens	blood plasma	374	not applicable	not available	38	Female	not available	Normal	depleted	374	not applicable	RHD01_454_1	proteomic profiling by mass spectrometry	RHD01_454_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_454_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-374	Homo sapiens	blood plasma	374	not applicable	not available	38	Female	not available	Normal	depleted	374	not applicable	RHD01_454_2	proteomic profiling by mass spectrometry	RHD01_454_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_454_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-375	Homo sapiens	blood plasma	375	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	375	not applicable	RHD01_455_1	proteomic profiling by mass spectrometry	RHD01_455_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_455_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-375	Homo sapiens	blood plasma	375	not applicable	not available	30	Female	not available	Rheumatic Heart Disease	depleted	375	not applicable	RHD01_455_2	proteomic profiling by mass spectrometry	RHD01_455_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_455_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-376	Homo sapiens	blood plasma	376	not applicable	not available	32	Male	not available	Rheumatic Heart Disease	depleted	376	not applicable	RHD01_456_1	proteomic profiling by mass spectrometry	RHD01_456_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_456_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-376	Homo sapiens	blood plasma	376	not applicable	not available	32	Male	not available	Rheumatic Heart Disease	depleted	376	not applicable	RHD01_456_2	proteomic profiling by mass spectrometry	RHD01_456_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_456_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-377	Homo sapiens	blood plasma	377	not applicable	not available	7	Female	not available	Rheumatic Heart Disease	depleted	377	not applicable	RHD01_45_1	proteomic profiling by mass spectrometry	RHD01_45_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_45_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-377	Homo sapiens	blood plasma	377	not applicable	not available	7	Female	not available	Rheumatic Heart Disease	depleted	377	not applicable	RHD01_45_2	proteomic profiling by mass spectrometry	RHD01_45_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_45_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-378	Homo sapiens	blood plasma	378	not applicable	not available	8	Female	not available	Rheumatic Heart Disease	depleted	378	not applicable	RHD01_46_1	proteomic profiling by mass spectrometry	RHD01_46_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_46_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-378	Homo sapiens	blood plasma	378	not applicable	not available	8	Female	not available	Rheumatic Heart Disease	depleted	378	not applicable	RHD01_46_2	proteomic profiling by mass spectrometry	RHD01_46_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_46_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-379	Homo sapiens	blood plasma	379	not applicable	not available	34	Male	not available	Rheumatic Heart Disease	depleted	379	not applicable	RHD01_47_1	proteomic profiling by mass spectrometry	RHD01_47_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_47_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-379	Homo sapiens	blood plasma	379	not applicable	not available	34	Male	not available	Rheumatic Heart Disease	depleted	379	not applicable	RHD01_47_2	proteomic profiling by mass spectrometry	RHD01_47_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_47_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-380	Homo sapiens	blood plasma	380	not applicable	not available	21	Male	not available	Normal	depleted	380	not applicable	RHD01_48_1	proteomic profiling by mass spectrometry	RHD01_48_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_48_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-380	Homo sapiens	blood plasma	380	not applicable	not available	21	Male	not available	Normal	depleted	380	not applicable	RHD01_48_2	proteomic profiling by mass spectrometry	RHD01_48_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_48_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-381	Homo sapiens	blood plasma	381	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	381	not applicable	RHD01_49_1	proteomic profiling by mass spectrometry	RHD01_49_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_49_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-381	Homo sapiens	blood plasma	381	not applicable	not available	16	Female	not available	Rheumatic Heart Disease	depleted	381	not applicable	RHD01_49_2	proteomic profiling by mass spectrometry	RHD01_49_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_49_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-382	Homo sapiens	blood plasma	382	not applicable	not available	43	Male	not available	Rheumatic Heart Disease	depleted	382	not applicable	RHD01_4_1	proteomic profiling by mass spectrometry	RHD01_4_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_4_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-382	Homo sapiens	blood plasma	382	not applicable	not available	43	Male	not available	Rheumatic Heart Disease	depleted	382	not applicable	RHD01_4_2	proteomic profiling by mass spectrometry	RHD01_4_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_4_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-383	Homo sapiens	blood plasma	383	not applicable	not available	28	Female	not available	Rheumatic Heart Disease	depleted	383	not applicable	RHD01_50_1	proteomic profiling by mass spectrometry	RHD01_50_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_50_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-383	Homo sapiens	blood plasma	383	not applicable	not available	28	Female	not available	Rheumatic Heart Disease	depleted	383	not applicable	RHD01_50_2	proteomic profiling by mass spectrometry	RHD01_50_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_50_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-384	Homo sapiens	blood plasma	384	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	384	not applicable	RHD01_51_1	proteomic profiling by mass spectrometry	RHD01_51_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_51_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-384	Homo sapiens	blood plasma	384	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	384	not applicable	RHD01_51_2	proteomic profiling by mass spectrometry	RHD01_51_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_51_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-385	Homo sapiens	blood plasma	385	not applicable	not available	24	Female	not available	Rheumatic Heart Disease	depleted	385	not applicable	RHD01_52_1	proteomic profiling by mass spectrometry	RHD01_52_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_52_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-385	Homo sapiens	blood plasma	385	not applicable	not available	24	Female	not available	Rheumatic Heart Disease	depleted	385	not applicable	RHD01_52_2	proteomic profiling by mass spectrometry	RHD01_52_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_52_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-386	Homo sapiens	blood plasma	386	not applicable	not available	27	Female	not available	Rheumatic Heart Disease	depleted	386	not applicable	RHD01_53_1	proteomic profiling by mass spectrometry	RHD01_53_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_53_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-386	Homo sapiens	blood plasma	386	not applicable	not available	27	Female	not available	Rheumatic Heart Disease	depleted	386	not applicable	RHD01_53_2	proteomic profiling by mass spectrometry	RHD01_53_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_53_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-387	Homo sapiens	blood plasma	387	not applicable	not available	32	Female	not available	Normal	depleted	387	not applicable	RHD01_55_1	proteomic profiling by mass spectrometry	RHD01_55_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_55_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-387	Homo sapiens	blood plasma	387	not applicable	not available	32	Female	not available	Normal	depleted	387	not applicable	RHD01_55_2	proteomic profiling by mass spectrometry	RHD01_55_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_55_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-388	Homo sapiens	blood plasma	388	not applicable	not available	26	Male	not available	Normal	depleted	388	not applicable	RHD01_56_1	proteomic profiling by mass spectrometry	RHD01_56_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_56_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-388	Homo sapiens	blood plasma	388	not applicable	not available	26	Male	not available	Normal	depleted	388	not applicable	RHD01_56_2	proteomic profiling by mass spectrometry	RHD01_56_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_56_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-389	Homo sapiens	blood plasma	389	not applicable	not available	8	Male	not available	Rheumatic Heart Disease	depleted	389	not applicable	RHD01_57_1	proteomic profiling by mass spectrometry	RHD01_57_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_57_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-389	Homo sapiens	blood plasma	389	not applicable	not available	8	Male	not available	Rheumatic Heart Disease	depleted	389	not applicable	RHD01_57_2	proteomic profiling by mass spectrometry	RHD01_57_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_57_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-390	Homo sapiens	blood plasma	390	not applicable	not available	32	Female	not available	Normal	depleted	390	not applicable	RHD01_58_1	proteomic profiling by mass spectrometry	RHD01_58_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_58_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-390	Homo sapiens	blood plasma	390	not applicable	not available	32	Female	not available	Normal	depleted	390	not applicable	RHD01_58_2	proteomic profiling by mass spectrometry	RHD01_58_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_58_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-391	Homo sapiens	blood plasma	391	not applicable	not available	62	Female	not available	Rheumatic Heart Disease	depleted	391	not applicable	RHD01_59_1	proteomic profiling by mass spectrometry	RHD01_59_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_59_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-391	Homo sapiens	blood plasma	391	not applicable	not available	62	Female	not available	Rheumatic Heart Disease	depleted	391	not applicable	RHD01_59_2	proteomic profiling by mass spectrometry	RHD01_59_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_59_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-392	Homo sapiens	blood plasma	392	not applicable	not available	23	Male	not available	Normal	depleted	392	not applicable	RHD01_5_1	proteomic profiling by mass spectrometry	RHD01_5_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_5_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-392	Homo sapiens	blood plasma	392	not applicable	not available	23	Male	not available	Normal	depleted	392	not applicable	RHD01_5_2	proteomic profiling by mass spectrometry	RHD01_5_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_5_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-393	Homo sapiens	blood plasma	393	not applicable	not available	24	Female	not available	Normal	depleted	393	not applicable	RHD01_60_1	proteomic profiling by mass spectrometry	RHD01_60_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_60_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-393	Homo sapiens	blood plasma	393	not applicable	not available	24	Female	not available	Normal	depleted	393	not applicable	RHD01_60_2	proteomic profiling by mass spectrometry	RHD01_60_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_60_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-394	Homo sapiens	blood plasma	394	not applicable	not available	24	Female	not available	Normal	depleted	394	not applicable	RHD01_61_1	proteomic profiling by mass spectrometry	RHD01_61_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_61_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-394	Homo sapiens	blood plasma	394	not applicable	not available	24	Female	not available	Normal	depleted	394	not applicable	RHD01_61_2	proteomic profiling by mass spectrometry	RHD01_61_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_61_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-395	Homo sapiens	blood plasma	395	not applicable	not available	22	Female	not available	Rheumatic Heart Disease	depleted	395	not applicable	RHD01_62_1	proteomic profiling by mass spectrometry	RHD01_62_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_62_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-395	Homo sapiens	blood plasma	395	not applicable	not available	22	Female	not available	Rheumatic Heart Disease	depleted	395	not applicable	RHD01_62_2	proteomic profiling by mass spectrometry	RHD01_62_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_62_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-396	Homo sapiens	blood plasma	396	not applicable	not available	54	Male	not available	Normal	depleted	396	not applicable	RHD01_63_1	proteomic profiling by mass spectrometry	RHD01_63_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_63_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-396	Homo sapiens	blood plasma	396	not applicable	not available	54	Male	not available	Normal	depleted	396	not applicable	RHD01_63_2	proteomic profiling by mass spectrometry	RHD01_63_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_63_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-397	Homo sapiens	blood plasma	397	not applicable	not available	72	Female	not available	Rheumatic Heart Disease	depleted	397	not applicable	RHD01_64_1	proteomic profiling by mass spectrometry	RHD01_64_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_64_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-397	Homo sapiens	blood plasma	397	not applicable	not available	72	Female	not available	Rheumatic Heart Disease	depleted	397	not applicable	RHD01_64_2	proteomic profiling by mass spectrometry	RHD01_64_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_64_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-398	Homo sapiens	blood plasma	398	not applicable	not available	47	Female	not available	Normal	depleted	398	not applicable	RHD01_65_1	proteomic profiling by mass spectrometry	RHD01_65_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_65_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-398	Homo sapiens	blood plasma	398	not applicable	not available	47	Female	not available	Normal	depleted	398	not applicable	RHD01_65_2	proteomic profiling by mass spectrometry	RHD01_65_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_65_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-399	Homo sapiens	blood plasma	399	not applicable	not available	35	Female	not available	Rheumatic Heart Disease	depleted	399	not applicable	RHD01_66_1	proteomic profiling by mass spectrometry	RHD01_66_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_66_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-399	Homo sapiens	blood plasma	399	not applicable	not available	35	Female	not available	Rheumatic Heart Disease	depleted	399	not applicable	RHD01_66_2	proteomic profiling by mass spectrometry	RHD01_66_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_66_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-400	Homo sapiens	blood plasma	400	not applicable	not available	23	Female	not available	Normal	depleted	400	not applicable	RHD01_67_1	proteomic profiling by mass spectrometry	RHD01_67_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_67_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-400	Homo sapiens	blood plasma	400	not applicable	not available	23	Female	not available	Normal	depleted	400	not applicable	RHD01_67_2	proteomic profiling by mass spectrometry	RHD01_67_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_67_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-401	Homo sapiens	blood plasma	401	not applicable	not available	43	Female	not available	Rheumatic Heart Disease	depleted	401	not applicable	RHD01_68_1	proteomic profiling by mass spectrometry	RHD01_68_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_68_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-401	Homo sapiens	blood plasma	401	not applicable	not available	43	Female	not available	Rheumatic Heart Disease	depleted	401	not applicable	RHD01_68_2	proteomic profiling by mass spectrometry	RHD01_68_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_68_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-402	Homo sapiens	blood plasma	402	not applicable	not available	15	Male	not available	Normal	depleted	402	not applicable	RHD01_69_1	proteomic profiling by mass spectrometry	RHD01_69_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_69_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-402	Homo sapiens	blood plasma	402	not applicable	not available	15	Male	not available	Normal	depleted	402	not applicable	RHD01_69_2	proteomic profiling by mass spectrometry	RHD01_69_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_69_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-403	Homo sapiens	blood plasma	403	not applicable	not available	45	Female	not available	Normal	depleted	403	not applicable	RHD01_6_1	proteomic profiling by mass spectrometry	RHD01_6_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_6_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-403	Homo sapiens	blood plasma	403	not applicable	not available	45	Female	not available	Normal	depleted	403	not applicable	RHD01_6_2	proteomic profiling by mass spectrometry	RHD01_6_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_6_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-404	Homo sapiens	blood plasma	404	not applicable	not available	33	Male	not available	Normal	depleted	404	not applicable	RHD01_70_1	proteomic profiling by mass spectrometry	RHD01_70_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_70_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-404	Homo sapiens	blood plasma	404	not applicable	not available	33	Male	not available	Normal	depleted	404	not applicable	RHD01_70_2	proteomic profiling by mass spectrometry	RHD01_70_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_70_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-405	Homo sapiens	blood plasma	405	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	405	not applicable	RHD01_71_1	proteomic profiling by mass spectrometry	RHD01_71_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_71_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-405	Homo sapiens	blood plasma	405	not applicable	not available	29	Female	not available	Rheumatic Heart Disease	depleted	405	not applicable	RHD01_71_2	proteomic profiling by mass spectrometry	RHD01_71_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_71_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-406	Homo sapiens	blood plasma	406	not applicable	not available	49	Male	not available	Normal	depleted	406	not applicable	RHD01_72_1	proteomic profiling by mass spectrometry	RHD01_72_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_72_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-406	Homo sapiens	blood plasma	406	not applicable	not available	49	Male	not available	Normal	depleted	406	not applicable	RHD01_72_2	proteomic profiling by mass spectrometry	RHD01_72_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_72_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-407	Homo sapiens	blood plasma	407	not applicable	not available	35	Female	not available	Normal	depleted	407	not applicable	RHD01_73_1	proteomic profiling by mass spectrometry	RHD01_73_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_73_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-407	Homo sapiens	blood plasma	407	not applicable	not available	35	Female	not available	Normal	depleted	407	not applicable	RHD01_73_2	proteomic profiling by mass spectrometry	RHD01_73_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_73_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-408	Homo sapiens	blood plasma	408	not applicable	not available	18	Male	not available	Rheumatic Heart Disease	depleted	408	not applicable	RHD01_74_1	proteomic profiling by mass spectrometry	RHD01_74_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_74_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-408	Homo sapiens	blood plasma	408	not applicable	not available	18	Male	not available	Rheumatic Heart Disease	depleted	408	not applicable	RHD01_74_2	proteomic profiling by mass spectrometry	RHD01_74_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_74_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-409	Homo sapiens	blood plasma	409	not applicable	not available	36	Female	not available	Normal	depleted	409	not applicable	RHD01_75_1	proteomic profiling by mass spectrometry	RHD01_75_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_75_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-409	Homo sapiens	blood plasma	409	not applicable	not available	36	Female	not available	Normal	depleted	409	not applicable	RHD01_75_2	proteomic profiling by mass spectrometry	RHD01_75_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_75_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-410	Homo sapiens	blood plasma	410	not applicable	not available	34	Male	not available	Normal	depleted	410	not applicable	RHD01_76_1	proteomic profiling by mass spectrometry	RHD01_76_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_76_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-410	Homo sapiens	blood plasma	410	not applicable	not available	34	Male	not available	Normal	depleted	410	not applicable	RHD01_76_2	proteomic profiling by mass spectrometry	RHD01_76_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_76_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-411	Homo sapiens	blood plasma	411	not applicable	not available	14	Female	not available	Rheumatic Heart Disease	depleted	411	not applicable	RHD01_77_1	proteomic profiling by mass spectrometry	RHD01_77_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_77_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-411	Homo sapiens	blood plasma	411	not applicable	not available	14	Female	not available	Rheumatic Heart Disease	depleted	411	not applicable	RHD01_77_2	proteomic profiling by mass spectrometry	RHD01_77_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_77_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-412	Homo sapiens	blood plasma	412	not applicable	not available	31	Female	not available	Rheumatic Heart Disease	depleted	412	not applicable	RHD01_78_1	proteomic profiling by mass spectrometry	RHD01_78_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_78_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-412	Homo sapiens	blood plasma	412	not applicable	not available	31	Female	not available	Rheumatic Heart Disease	depleted	412	not applicable	RHD01_78_2	proteomic profiling by mass spectrometry	RHD01_78_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_78_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-413	Homo sapiens	blood plasma	413	not applicable	not available	55	Female	not available	Rheumatic Heart Disease	depleted	413	not applicable	RHD01_79_1	proteomic profiling by mass spectrometry	RHD01_79_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_79_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-413	Homo sapiens	blood plasma	413	not applicable	not available	55	Female	not available	Rheumatic Heart Disease	depleted	413	not applicable	RHD01_79_2	proteomic profiling by mass spectrometry	RHD01_79_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_79_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-414	Homo sapiens	blood plasma	414	not applicable	not available	21	Female	not available	Normal	depleted	414	not applicable	RHD01_7_1	proteomic profiling by mass spectrometry	RHD01_7_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_7_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-414	Homo sapiens	blood plasma	414	not applicable	not available	21	Female	not available	Normal	depleted	414	not applicable	RHD01_7_2	proteomic profiling by mass spectrometry	RHD01_7_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_7_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-415	Homo sapiens	blood plasma	415	not applicable	not available	19	Female	not available	Rheumatic Heart Disease	depleted	415	not applicable	RHD01_80_1	proteomic profiling by mass spectrometry	RHD01_80_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_80_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-415	Homo sapiens	blood plasma	415	not applicable	not available	19	Female	not available	Rheumatic Heart Disease	depleted	415	not applicable	RHD01_80_2	proteomic profiling by mass spectrometry	RHD01_80_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_80_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-416	Homo sapiens	blood plasma	416	not applicable	not available	19	Male	not available	Normal	depleted	416	not applicable	RHD01_81_1	proteomic profiling by mass spectrometry	RHD01_81_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_81_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-416	Homo sapiens	blood plasma	416	not applicable	not available	19	Male	not available	Normal	depleted	416	not applicable	RHD01_81_2	proteomic profiling by mass spectrometry	RHD01_81_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_81_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-417	Homo sapiens	blood plasma	417	not applicable	not available	42	Female	not available	Normal	depleted	417	not applicable	RHD01_82_1	proteomic profiling by mass spectrometry	RHD01_82_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_82_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-417	Homo sapiens	blood plasma	417	not applicable	not available	42	Female	not available	Normal	depleted	417	not applicable	RHD01_82_2	proteomic profiling by mass spectrometry	RHD01_82_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_82_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-418	Homo sapiens	blood plasma	418	not applicable	not available	42	Female	not available	Rheumatic Heart Disease	depleted	418	not applicable	RHD01_83_1	proteomic profiling by mass spectrometry	RHD01_83_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_83_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-418	Homo sapiens	blood plasma	418	not applicable	not available	42	Female	not available	Rheumatic Heart Disease	depleted	418	not applicable	RHD01_83_2	proteomic profiling by mass spectrometry	RHD01_83_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_83_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-419	Homo sapiens	blood plasma	419	not applicable	not available	21	Male	not available	Rheumatic Heart Disease	depleted	419	not applicable	RHD01_84_1	proteomic profiling by mass spectrometry	RHD01_84_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_84_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-419	Homo sapiens	blood plasma	419	not applicable	not available	21	Male	not available	Rheumatic Heart Disease	depleted	419	not applicable	RHD01_84_2	proteomic profiling by mass spectrometry	RHD01_84_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_84_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-420	Homo sapiens	blood plasma	420	not applicable	not available	32	Female	not available	Normal	depleted	420	not applicable	RHD01_86_1	proteomic profiling by mass spectrometry	RHD01_86_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_86_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-420	Homo sapiens	blood plasma	420	not applicable	not available	32	Female	not available	Normal	depleted	420	not applicable	RHD01_86_2	proteomic profiling by mass spectrometry	RHD01_86_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_86_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-421	Homo sapiens	blood plasma	421	not applicable	not available	39	Female	not available	Normal	depleted	421	not applicable	RHD01_87_1	proteomic profiling by mass spectrometry	RHD01_87_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_87_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-421	Homo sapiens	blood plasma	421	not applicable	not available	39	Female	not available	Normal	depleted	421	not applicable	RHD01_87_2	proteomic profiling by mass spectrometry	RHD01_87_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_87_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-422	Homo sapiens	blood plasma	422	not applicable	not available	44	Female	not available	Rheumatic Heart Disease	depleted	422	not applicable	RHD01_88_1	proteomic profiling by mass spectrometry	RHD01_88_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_88_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-422	Homo sapiens	blood plasma	422	not applicable	not available	44	Female	not available	Rheumatic Heart Disease	depleted	422	not applicable	RHD01_88_2	proteomic profiling by mass spectrometry	RHD01_88_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_88_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-423	Homo sapiens	blood plasma	423	not applicable	not available	32	Female	not available	Normal	depleted	423	not applicable	RHD01_89_1	proteomic profiling by mass spectrometry	RHD01_89_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_89_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-423	Homo sapiens	blood plasma	423	not applicable	not available	32	Female	not available	Normal	depleted	423	not applicable	RHD01_89_2	proteomic profiling by mass spectrometry	RHD01_89_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_89_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-424	Homo sapiens	blood plasma	424	not applicable	not available	22	Female	not available	Normal	depleted	424	not applicable	RHD01_8_1	proteomic profiling by mass spectrometry	RHD01_8_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_8_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-424	Homo sapiens	blood plasma	424	not applicable	not available	22	Female	not available	Normal	depleted	424	not applicable	RHD01_8_2	proteomic profiling by mass spectrometry	RHD01_8_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_8_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-425	Homo sapiens	blood plasma	425	not applicable	not available	7	Male	not available	Rheumatic Heart Disease	depleted	425	not applicable	RHD01_90_1	proteomic profiling by mass spectrometry	RHD01_90_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_90_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-425	Homo sapiens	blood plasma	425	not applicable	not available	7	Male	not available	Rheumatic Heart Disease	depleted	425	not applicable	RHD01_90_2	proteomic profiling by mass spectrometry	RHD01_90_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_90_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-426	Homo sapiens	blood plasma	426	not applicable	not available	24	Female	not available	Rheumatic Heart Disease	depleted	426	not applicable	RHD01_91_1	proteomic profiling by mass spectrometry	RHD01_91_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_91_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-426	Homo sapiens	blood plasma	426	not applicable	not available	24	Female	not available	Rheumatic Heart Disease	depleted	426	not applicable	RHD01_91_2	proteomic profiling by mass spectrometry	RHD01_91_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_91_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-427	Homo sapiens	blood plasma	427	not applicable	not available	27	Female	not available	Normal	depleted	427	not applicable	RHD01_92_1	proteomic profiling by mass spectrometry	RHD01_92_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_92_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-427	Homo sapiens	blood plasma	427	not applicable	not available	27	Female	not available	Normal	depleted	427	not applicable	RHD01_92_2	proteomic profiling by mass spectrometry	RHD01_92_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_92_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-428	Homo sapiens	blood plasma	428	not applicable	not available	22	Female	not available	Rheumatic Heart Disease	depleted	428	not applicable	RHD01_93_1	proteomic profiling by mass spectrometry	RHD01_93_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_93_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-428	Homo sapiens	blood plasma	428	not applicable	not available	22	Female	not available	Rheumatic Heart Disease	depleted	428	not applicable	RHD01_93_2	proteomic profiling by mass spectrometry	RHD01_93_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_93_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-429	Homo sapiens	blood plasma	429	not applicable	not available	13	Female	not available	Rheumatic Heart Disease	depleted	429	not applicable	RHD01_94_1	proteomic profiling by mass spectrometry	RHD01_94_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_94_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-429	Homo sapiens	blood plasma	429	not applicable	not available	13	Female	not available	Rheumatic Heart Disease	depleted	429	not applicable	RHD01_94_2	proteomic profiling by mass spectrometry	RHD01_94_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_94_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-430	Homo sapiens	blood plasma	430	not applicable	not available	24	Male	not available	Rheumatic Heart Disease	depleted	430	not applicable	RHD01_95_1	proteomic profiling by mass spectrometry	RHD01_95_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_95_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-430	Homo sapiens	blood plasma	430	not applicable	not available	24	Male	not available	Rheumatic Heart Disease	depleted	430	not applicable	RHD01_95_2	proteomic profiling by mass spectrometry	RHD01_95_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_95_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-431	Homo sapiens	blood plasma	431	not applicable	not available	43	Male	not available	Normal	depleted	431	not applicable	RHD01_96_1	proteomic profiling by mass spectrometry	RHD01_96_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_96_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-431	Homo sapiens	blood plasma	431	not applicable	not available	43	Male	not available	Normal	depleted	431	not applicable	RHD01_96_2	proteomic profiling by mass spectrometry	RHD01_96_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_96_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-432	Homo sapiens	blood plasma	432	not applicable	not available	18	Female	not available	Normal	depleted	432	not applicable	RHD01_97_1	proteomic profiling by mass spectrometry	RHD01_97_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_97_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-432	Homo sapiens	blood plasma	432	not applicable	not available	18	Female	not available	Normal	depleted	432	not applicable	RHD01_97_2	proteomic profiling by mass spectrometry	RHD01_97_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_97_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-433	Homo sapiens	blood plasma	433	not applicable	not available	18	Male	not available	Normal	depleted	433	not applicable	RHD01_98_1	proteomic profiling by mass spectrometry	RHD01_98_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_98_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-433	Homo sapiens	blood plasma	433	not applicable	not available	18	Male	not available	Normal	depleted	433	not applicable	RHD01_98_2	proteomic profiling by mass spectrometry	RHD01_98_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_98_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-434	Homo sapiens	blood plasma	434	not applicable	not available	22	Male	not available	Rheumatic Heart Disease	depleted	434	not applicable	RHD01_99_1	proteomic profiling by mass spectrometry	RHD01_99_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_99_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-434	Homo sapiens	blood plasma	434	not applicable	not available	22	Male	not available	Rheumatic Heart Disease	depleted	434	not applicable	RHD01_99_2	proteomic profiling by mass spectrometry	RHD01_99_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_99_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-435	Homo sapiens	blood plasma	435	not applicable	not available	75	Female	not available	Normal	depleted	435	not applicable	RHD01_9_1	proteomic profiling by mass spectrometry	RHD01_9_1.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_9_1.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	1	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
PXD030598-Sample-435	Homo sapiens	blood plasma	435	not applicable	not available	75	Female	not available	Normal	depleted	435	not applicable	RHD01_9_2	proteomic profiling by mass spectrometry	RHD01_9_2.wiff	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2022/04/PXD030598/RHD01_9_2.wiff	1	no fractionation	AC=MS:1002038;NT=label free sample	2	AC=MS:MS:1002533; NT=TripleTOF 6600	NT=Trypsin; AC=MS:1001251	AC=MS:1002533; NT=6600 TripleTOF	AC=MS:1000491; NT=Dionex	NT=Data-Independent Acquisition;AC=NCIT:C161786	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	10 ppm	10 ppm	blood plasma
